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There is convergent evidence for shifts in female psychology across the menstrual 
cycle. Specifically, women have been shown to display distinct shifts in their 
preferences and behaviour as they transition from fertile to non-fertile cycle phases 
(reviewed in Gangestad & Thornhill, 2008). Such shifts correspond to fluctuations 
in levels of naturally occurring hormones. However, the use of hormonal 
contraceptives (henceforth HC’s), which is indeed widespread, is known to modify 
hormone levels. I will argue that, because HC’s suppress normal hormonal 
fluctuation, their use disrupts natural female preferences and behaviours which 
occur across the menstrual cycle. In doing so, I will provide indication which 
suggests that this disruption may have psychological consequences for the dynamics 
of actual relationships. 
 
The HC pill is the most widely studied form of medication in the world (Hather et 
al., 2007). There is, without question, a valuable body of existing research on the 
impact of HC use. However, to date much of this research has focused on the 
physical risk factors associated with use (for reviews see for example Smith et al., 
2003, cervical cancer; Vandenbroucke et al., 2001, venous thrombosis; Martins et 
al., 2006, bone health) or on the social political influence that the introduction of 
reliable and reversible contraception has had on the role of women within society 
(e.g., Goldin & Katz, 2002). It is no surprise that such vital and immediately 
relevant topics have received so much attention. However, remarkably relatively 
few studies have examined the psychological effects associated with HC use. 
Examining how the use of HC’s impacts behaviour in social relationships may 
contribute to women’s ability to make more informed decisions to use HC’s.  
 
I approached the study of HC effects on female psychology from an evolutionary 
psychology perspective. Evolutionary psychology attempts to study human 
behaviour from an adaptive perspective. Evolution by natural selection is the source 
through which all physiological systems are structured. Consequently, evolutionary 
psychology uses a selectionist approach which considers how traits may help an 
organism to survive and/or reproduce. The use of an evolutionary approach 
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provided pertinent theoretical insights into what behavioural changes one might 
expect to see as a result of HC use. Research in this area conducted without thought 
for how and why traits evolve would lead to uninformed functional theorizing 
which in turn would generate fruitless scientific theories (Daly & Wilson, 1999). 
 
In the subsequent sections of this introduction I will present an overview of the 
physiology of the female menstrual cycle and describe the pattern of psychological 
changes known to occur at fertile versus non-fertile cycle stages. I will then outline 
the history of HC’s and their method of action. Together, these sections aim to 
provide readers with a basic foundation of medical and consumer expectations of 
HC’s. Finally, I will briefly summarize the current psychological literature on HC 
effects before concluding with an outline of the empirical chapters contained within 
this thesis. 
 
Physiology of the female reproductive cycle 
 
The female reproductive cycle, commonly referred to as the menstrual cycle, lasts 
approximately one month and results in changes to a woman’s ovaries and uterus. 
Among Dutch women the onset of the menstrual cycle, known as menarche, takes 
place at approximately age 13 (e.g., a median of 13.15 years was reported Mul et 
al., 2001). However, age at menarche among the Dutch has been shown to be 
influenced by additional factors including height and body mass index (BMI) (Mul 
et al., 2001). Other research has shown that age at menarche varies as a function of 
a number of other variables including nutritional status (Tena-Sempere, 2008), 
ethnicity (Wu et al., 2001) and geography (Morabia et al., 1998).  
 
Broadly speaking, changes occurring at the ovaries during the reproductive cycle 
can be divided into three main stages: the follicular phase, the ovulatory phase and 
the luteal phase. The length of the reproductive cycle varies between women. An 
average of 28 days is typical (e.g., Cole et al., 2009 report an average cycle length 
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of 27.7 days ± 2.4 days), however anywhere between 21 to 45 days is considered 
normal (Hornstein & Schwerin, 2013)1.  
 
At the start of the reproductive cycle, during the follicular phase, due to an 
increasing level of the gonadotropin follicle-stimulating hormone (FSH) several 
follicles will begin to grow. Growing follicles produce estrogen. Typically, one 
follicle will grow at a faster rate than the others. This follicle is known as the 
“dominant follicle” as it produces more estrogen than the smaller competing 
follicles (Mihm & Evans, 2008). The production of estrogen from the dominant 
follicle, in combination with high existing levels of FSH triggers the development 
of luteinizing hormone (LH) binding sites. Concurrently, the dominant follicle 
develops an antrum and becomes a mature secondary follicle. When this occurs, 
inhibin, a peptide hormone, is secreted which suppresses previous FSH secretion 
from the pituitary gland. In the absence of high FSH the smaller competing follicles 
soon die off. This process ensures that only one follicle matures in a given month 
(Hornstein & Schwerin, 2013)2. 
 
The dominant follicle then produces increasing levels of estrogen in an accelerated 
fashion, creating a further increase in LH binding sites, which in turn, through a 
positive feedback loop with the pituitary gland, increases levels of LH. Mid-cycle 
estrogen surges resulting in a corresponding surge in LH and FSH (See Figure 1 and 
Figure 2). It is at this time that ovulation, the discharge of the ovum from the ovary, 
occurs. In an average cycle ovulation occurs around day 14. After ovulation, during 
the luteal cycle phase, the granulosa cells (the inner layer of the follicle) left behind 
begin to secrete progesterone and some estrogen, and through a series of metabolic 
                                                            
1  Variation in cycle length between women can occur as a result of numerous factors that 
influence hormone levels such as differences in age or weight, or social environmental 
factors such as stress levels and smoking (Harlow & Matanoski, 1991; Rowland et al., 2002). 
2 In rare cases when two or more follicles develop the possibility for multiple births occurs 
(e.g., fraternal twins). 
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changes become the corpus luteum. The corpus luteum continues to secrete estrogen 
and progesterone. While this is occurring FSH and LH drop dramatically. Typically 
around day 21 the corpus luteum begins to degenerate causing a sudden drop in 
estrogen and progesterone hormones. These processes cause the endometrium, a 
mucus lining of the uterus, to shed. This shedding, termed menses, or more 
commonly, the menstrual period, results in the flow roughly 50 ml of blood and 
tissue from the uterine cavity out of the vagina. A typical menses lasts two to seven 
days. In the absence of negative feedback loops with estrogen and progesterone 
(due to cyclical changes in the ovary), FSH and LH begin to increase and a new 
cycle starts (Hornstein & Schwerin, 2013). The female reproductive cycle re-occurs 
from menarche until menopause and marks the reproductive period in a woman’s 
life.  
 
Importantly, conception is only possible during specific stages of the reproductive 
cycle. Conception risk is the highest just prior to ovulation in the late follicular 
phase. The LH surge is typically used as an indicator of the fertile phase, since LH 
levels increase dramatically just prior to ovulation. For example, ovulatory 
detection kits, used by women trying to get pregnant, work through measuring LH 
levels in the urine (e.g., Nielsen et al., 2001). With the exception of the brief 
window of time between the LH surge and ovulation, throughout the rest of the 


























Figure 1. Pattern of hormone blood levels of estrogen (filled) and progesterone 
(empty) across a typical 28-day menstrual cycle. Estrogen peaks mid-cycle around 














Figure 2. Level of gonadotropic hormones of FSH (empty) and LH (filled) across a 
typical 28-day menstrual cycle. Both LH and FSH peak mid-cycle.  
 
General Introduction 
Page | 15 
 
Evolutionary psychology and the reproductive cycle  
 
To begin this section, for clarity, I will explicitly outline key terminology pertinent 
to this discussion. Herein, I will use the term fitness to refer to the ability of an 
organism to survive and reproduce offspring into the next generation. The term 
adaptation will be used to describe a trait which helps an organism to enhance its 
fitness. An adaptation is therefore a trait which by virtue of its presence provides an 
organism with a survival advantage or enables it to reproduce healthy offspring at a 
higher rate than it otherwise would in the absence of the trait. The term costly trait 
refers to a feature which requires a lot of energy or time to maintain and in some 
way enhances the possessors fitness. Finally, ‘good gene traits’ refer to costly traits 
which may signal underlying health (Folstad & Karter, 1992).    
 
Recall from the previous section on the physiology of the female reproductive cycle 
that fertility only occurs during a brief window each month just prior to ovulation. 
At this time, in a range of species, females undergo overt physical changes that 
clearly signal their conception risk. This phenomenon is known as oestrus. For 
example, chimps and baboons display prominent sexual swellings when fertile 
(Dixson, 1983). Moreover, the actual quality of these sexual swellings has been 
shown to directly correlate with fitness outcomes, clearly indicating their value as 
honest cues of health and reproductive potential (Domb & Pagel, 2001). For many 
years human behavioural ecologists assumed that changes akin to these did not exist 
among human females (e.g., Etkin, 1964; Jolly, 1972; Alexander & Noonan, 1979; 
Burley, 1979; Spuhler, 1979; Symons, 1979). This conclusion was asserted based 
on the fact that women are sexually receptive throughout the entire cycle. That is, in 
humans sex is not restricted to phases of high fertility where conception is possible. 
   
However, in the past 15 years a growing body of evidence has disproven this idea. 
The ovulatory shift hypothesis, which was first proposed by Gangestad and 
Thornhill (1998; 2008), argues that women undergo systematic shifts in mating 
psychology across the reproductive cycle in relation to conception risk. That is, they 
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argued that women display a dual sexuality akin to oestrus in which female 
preferences and behaviours diverge in stages of high and low fertility. Gangestad 
and Thornhill (2008) stress that while women are receptive to sex throughout the 
cycle (known as extended sexuality) they exhibit distinct differences in mating 
related psychology when fertile. Dual sexuality is argued to function adaptively to 
enhance female fitness similarly to oestrus changes which occur in a number of 
non-human species (e.g., chimpanzees; Spritzer et al., 2005).  
 
Prior to elaborating on dual sexuality, a basic understanding of sex differences in 
reproductive investment is necessary. The small size and cheap cost of producing 
male sperm, relative to the large size and cost of producing female follicles, means 
that fewer females to males are able to reproduce at any given time. Accordingly, 
while each successive mating has the potential to increase male reproductive fitness, 
this is not true to the same extent for females (Bateman, 1948). This results in sex 
differences in ‘choosiness’ and fitness benefits with respect to engaging in sexual 
relationships. A full discussion of these differences is beyond the scope of this 
thesis. Most simply stated, based on the notion that women are the ‘limiting factor’ 
for reproduction and that males differ in their genetic quality, it makes little sense 
for women to indiscriminately mate with males. Thus women are selective in their 
mate choice and consider what benefits they can achieve from their partners. 
Broadly speaking, benefits can be direct or indirect. Direct benefits may come in the 
form of parental care, resource provisioning, and protection from parasites (given 
that men who are able to display costly traits are more likely to have lower parasite 
loads). Obtaining direct benefits has an immediate effect on reproductive fitness and 
is relevant to women throughout the cycle. Indirect benefits are acquired by pairing 
with males who have costly traits indicative of good genes. Indirect benefits come 
in the form of offspring health and survival. That is, females can benefit from 
mating with men who possess costly traits because the underlying good genes 
required to display costly traits will be inherited by any subsequent offspring. 
Women can therefore make use of phenotypic traits believed to signal underlying 
good genes to be discriminating their mate choice (Roberts & Little, 2008). 
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However, the potential value in acquiring indirect benefits varies across the cycle 
with conception risk. That is, the only time that pairing with an individual with 
good genes can provide indirect benefits is when conception is possible. Thus, a 
cycle-contingent shift in mating preferences for indicators of good genes would be 
adaptive. This is particularly true given that men with indicators of good genes have 
been shown to be less likely than other men to provide investment (e.g., Gangestad 
& Simpson, 2000) and are more sexually promiscuous (Boothroyd et al., 2008). 
This suggests that men who offer indirect benefits tend not to provide direct 
benefits. Of course, I acknowledge, the two need not be mutually exclusive.  
 
Based on these differential benefits, the ovulatory shift hypothesis argues that 
phases of fertility should therefore not be characterized as times of generalized 
sexual motivation or excitement, but rather as times of increased sexual motivation 
and excitement to specific male traits associated with good genes (Gangestad & 
Thornhill, 2008). The ovulatory shift hypothesis also argues that women’s increased 
fertile phase preference for these good genes should be specific to short-term, but 
not long-term, mating contexts (Gangestad & Thornhill, 1998). Research shows, for 
example, that when fertile, as compared to non-fertile, women demonstrate an 
increased preference for masculinity. This is considered adaptive because 
masculinity is thought to be a costly trait (Folstad & Karter, 1992). For example, 
when fertile women show increased preference for masculinity in male faces (e.g., 
Penton-Voak et al., 1999; Penton-Voak & Perrett, 2000; Johnston et al., 2001; Jones 
et al., 2005; Welling et al., 2007; Little & Jones, 2012), bodies (Little et al., 2007a; 
Gangestad et al., 2007), voices (e.g., Puts, 2005; Feinberg et al., 2006) and scents 
(e.g., Havlíček et al., 2005). Apart from physical preference shifts, research has also 
shown that near to ovulation women prefer greater degrees of behavioural 
masculinity. For example, women have been shown to prefer men who display 
greater levels of intrasexual (same-sex) competition and social presence more 
during fertile relative to non-fertile cycle stages (Gangestad et al., 2004).  
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Low levels of fluctuating asymmetry are likewise considered to be an indicator of 
good genes which reflect underlying quality, or at the very least, developmental 
stability. Findings related to symmetry preferences across the reproductive cycle are 
consistent with those with respect to masculinity: increased preference for 
symmetry as assessed in faces (e.g., Little et al., 2007b, but see also Koehler et al., 
2002; Koehler et al., 2006), bodies (Thornhill et al., 2003) and from scent (e.g., 
Gangestad and Thornhill, 1998; Thornhill & Gagestad, 1999; Rikowski & 
Grammer, 1999; Thornhill et al., 2003) has been found during fertile cycle phases. 
In addition to these traits, studies have shown that a limited number of good gene 
indicators believed to be related to mental fitness are preferred more by women 
when fertile as compared to when non-fertile. One example includes creative 
intelligence (Haselton & Miller, 2006).  
 
A woman’s ability to attract a male partner also varies with her conception risk. For 
example, female faces (Roberts et al., 2004; Bobst & Lobmaier, 2012) and voices 
(Bryant & Haselton, 2009; Pipitone & Gallup, 2008) are judged to be more 
attractive during fertile relative to non-fertile cycle stages. Similarly, men have been 
shown to rate scents of women in the fertile stage of the cycle as least intense and 
most attractive (Singh & Bronstad, 2001; Thornhill et al., 2003; Kuukasjärvi et al., 
2004; Havlíček et al., 2006; Gildersleeve et al., 2012). A variety of other features 
which are known to be important markers of attractiveness are also enhanced during 
fertility, for example, women become more symmetrical (Manning et al., 1996), 
have lower waist-to-hip ratios (Kirchengast & Gartner, 2002) and more appealing 
gaits (Gueguen, 2012). Preliminary evidence exists which suggests that, at least to 
some degree, women are cognizant of their increased physical attractiveness: 
women report greater self-perceived attractiveness or feelings of ‘sexiness’ when 
fertile as compared to when non-fertile (Haselton & Gangestad, 2006). However, 
this finding is made somewhat less clear when one considers research by Hill and 
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Shifts in self-perception, whether conscious or not, could however explain the 
finding that women’s behaviour also varies as a function of fertility. For example, 
women are known to dress more attractively when fertile as compared to non-fertile 
(e.g., Grammer et al., 2004; Haselton et al., 2007; Durante, Li & Haselton, 2008). 
Likewise research tracking female product use and spending has shown that women 
are more likely to use appearance enhancing products when fertile (Durante et al., 
2011; Saad & Stenstrom, 2012). Interestingly, at the same time as they focus 
increased effort on physical appearance, women also report increased desire to visit 
social venues such as nightclubs (Haselton & Gangestad, 2006). Frequenting social 
venues may place women at increased odds of meeting new men, which is 
consistent with that they are more interested in extra-pair men when fertile. For 
example, women are more likely to accept a courtship solicitation from a male 
when fertile (Geugeun, 2009). This is in line with other findings which show that 
women experience greater sexual desire and fantasies when fertile (Bullivant et al., 
2004), and that, among women in a relationship, these fantasies are directed towards 
extra-pair mates rather than the primary partner (Gangestad, Thornhill & Garver, 
2002). Perhaps the most compelling support for the notion that cyclical changes in 
female preferences and behaviour function adaptively to obtain fitness benefits is 
found in research which shows that extra-pair sexual desire when fertile is 
particularly strong when a woman perceives her primary partner to lack indicators 
of genetic quality such as symmetry (Gangestad, Thornhill & Garver-Apgar, 2005) 
or physical attractiveness (Haselton & Gangestad, 2006; Pillsworth & Haselton, 
2006). This implies that, when fertile, changes in a woman’s own physical 
attractiveness and altered preferences for features in men, motivates increased 
behavioural attention to mating-relevant stimuli particularly in instances when a 
woman is not already paired with a man she perceives to have costly good gene 
traits.  
 
The aforementioned fertile phase shifts in mate preferences, attractiveness and 
social behaviour beg the question of whether or not such changes are noticeable 
outside of the laboratory to social or romantic partners (Cobey & Buunk, 2012). To 
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date this possibility has been approached from two perspectives. In one line of 
research investigators have been testing the influence of fertility status on female-
female relationships. Since women vary in their quality, it is possible that fertile 
phases of the cycle are associated with increased female-female competition. A 
study by Fisher (2004) has indeed shown that women are more likely to derogate 
the faces of female competitors when fertile as compared to when non-fertile.3 This 
may be explained by the fact that women place a greater emphasis on mating effort 
at this time and are therefore more salient of, and degrading to, potential rivals. 
Research has yet to examine variation in women’s reactions to fertile versus non-
fertile rivals, and this therefore provides an interesting avenue for future research. In 
a second line of research, the possibility that male partners may adjust their 
behaviour as a response to cyclical changes in female attractiveness and behaviour 
is being studied. Current research on this theme shows that women report increased 
mate guarding when fertile as compared to non-fertile (Gangestad, Thornhill & 
Garver, 2002). Interestingly, perceptions of partner jealousy have been shown to be 
enhanced in circumstances where women perceive their male partner to be low in 
sexual desirability (Haselton & Gangestad, 2006). A recent study using male self-
reports of mate guarding has validated this idea: men self-report to be more vigilant 
of their partner when she is fertile as compared to non-fertile (manuscript in prep, 
communication with Thornhill 2012). Similarly, this study indicated that women 
report higher levels of self-assertive mate guarding behaviours towards their partner 
when fertile, while at the same time (especially when strongly attracted to extra-pair 
men) engaged in more behaviours which are unobservable to males that resist male 
vigilance or mate guarding. Miller and Maner (2010) suggested a proximate 
explanation for the link between female fertility status and male behaviour. These 
researchers showed that men exposed to the scents of fertile women maintained 
higher testosterone levels afterwards than men exposed to odours of women who 
were non-fertile. This finding may be explained in context to the challenge 
                                                            
3 Note that I have been unable to replicate this finding either as a direct replication or through 
use of survey measures as I present in Chapter 6.  
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hypothesis (reviewed in Archer, 2006) which describes how testosterone helps to 
facilitate a trade-off between male reproductive and parenting effort. High, or 
increased, testosterone is associated with mating activity. Therefore, higher relative 
testosterone levels after exposure to fertile female odours may represent an 
adaptation to seek sex when female conception risk is highest. Within a committed 
relationship, heightened testosterone in response to fertile scent might also serve to 
enhance male mate guarding ability since testosterone has been implicated in male 
competitive behaviour. However, a more recent study by Roney & Simmons (2012) 
has failed to replicate the work of Miller and Maner (2010) when using a crossover 
design in which men were unaware of the source (e.g., gender) of the odours they 
smelt. This suggests that mental imagery of women may impact the findings 
obtained by Miller and Maner (2010), and that scent alone does not fully explain the 
reported effects. In other work which measured changes in male behaviour, men 
have been shown to increase their use of non-conforming words when conversing 
with a fertile as compared to a non-fertile woman. Non-conforming words are 
thought to be associated with creativity or intelligence and therefore considered to 
be potential signals of male genetic quality (Coyle & Kascak, 2012).  
 
The aforementioned studies suggest that female fertility, while subtle, is not 
concealed. Instead, fertility is observable through shifts in mating preferences, 
increased same-sex competitive behaviour and changes in opposite sex mating 
behaviour. If cyclical shifts in these areas impact fitness outcomes, then use of HC’s 
may generate presently unrecognized negative consequences. Before discussing 
theses potential consequences, I will briefly provide a historical overview of the 
development of HC’s and their method of action.    
 
History of hormonal contraception  
 
Human females are somewhat unique in the animal kingdom in that they do not 
restrict sex to periods of fertility as is common in many non-human species. That is, 
women display an extended sexuality in which they are receptive to sex during both 
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fertile and non-fertile cycle stages. Women are even receptive to sex in instances 
where they are fertile but in which pregnancy is outwardly not desired. The 
prevention of pregnancy through the use of contraception is therefore, not 
surprisingly, an ancient practice. Women and midwives have passed on their 
knowledge of both hormonal and barrier methods for preventing pregnancy for 
centuries. For example, one of the first records of condom use by a man is from the 
16th century, when an Italian physician named Gabriele Falloppio devised a linen 
condom that was soaked in a chemical solution and then dried prior to use. 
Falloppio developed this device in an effort to protect against syphilis (Collier, 
2007). This may sound peculiar relative to today’s techniques, but traditions of 
contraception were widespread, and varied a great deal, long before the invention of 
the condom. In 1900 BC ancient Egyptian women made vaginal suppositories from 
plants, honey and acacia gum to prevent pregnancy (Riddle et al., 1994), while 
Indian women made suppositories from animal dung of elephants or crocodiles 
(Skuy, 1995). Women residing in Cyrene, on the coast of Libya, who created a 
potion which contained the resin of a plant, Silphium, from the giant fennel family, 
which was believed to have contraceptive properties. It was used locally by women, 
but also exported to nearby Greece and Syria to such an extent that it became 
extinct by 300 BC (Riddle et al., 1994). In other areas of the world women ingested 
extract from prayer bead seeds to obtain contraception that was understood to last 
for 13 months (Iwu, 1993). 
 
The HC pill, today’s most widely used form of contraception, differs substantially 
from methods used historically. However, an understanding of the antiquity of HC’s 
and contraception more generally is imperative to understand modern day HC’s. 
The political climate during the time HC’s were developed and introduced had a 
direct bearing upon how they were formulated and marketed. HC’s were first 
introduced in America on May 9th, 1960; however, work began on their 
development many decades prior. In many respects, HC’s were not solely an 
American invention (Marks, 2001). For example, by 1921 Ludwig Haberlandt, an 
Austrian physiologist, had already acknowledged from his research that it would be 
General Introduction 
Page | 23 
 
possible to generate an oral contraceptive comprised of hormones (reviewed in 
Simmer, 1975). At the time, this notion was entirely novel. Existing methods of 
contraception made use of physical barriers (e.g., condoms or diaphragms) which 
required mechanical application at the time of sex. The idea that effective 
contraception could be obtained hormonally and that use could be decoupled from 
the act of sex was tremendously innovative. In the aftermath of the First World War 
Heberlandt acknowledged that families would benefit from being able to space their 
births and reduce family size due to severe unemployment and supply problems. By 
1927, Haberlandt had conducted a number of animal studies which indicated that 
insertion of ovarian and placental extracts into female animals delivered 
contraceptive protection (Goldzieher, 1993).  
 
From that point onward however, Haberlandt encountered great obstruction 
politically by colleagues who felt his desire to create a HC was both morally and 
ethically unsound. This resistance made it problematic for him to initiate clinical 
trials of his natural hormone preparation. Eventually, in the 1930’s after 
encountering so much resistance Haberlandt registered his HC with the company G. 
Richter based out of Budapest, Hungary. In spite of acquiring this contract his work 
was still considered taboo. For example, Haberlandt was denied an academic 
promotion at his Catholic university. In response to his struggle with political 
pressures Haberlandt eventually committed suicide in 1932. Years later his drug 
would eventually be clinically tested (Haberlandt, 2009) and subsequent changes 
led to the development of the first Hungarian HC pill, Infecundin, in 1966 (Marks, 
2001). In the years that followed Heberlandt’s death other researchers began 
exploring recently developed synthetic hormones. European research groups led this 
chase: CIBA of Switzerland, Schering and Bohringer of Germany, Roussel of Paris 
and Organon of The Netherlands held a monopoly on production (Bullough, 1994). 
Researchers who saw the potential of using synthetic hormones to achieve reliable 
contraception were limited by high purchasing costs. Worse still, when researchers 
could obtain synthetic hormones to test in clinical trials the political climate often 
prohibited them from doing so. At the time, the notion of medicating healthy 
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women, solely for contraceptive purposes, was considered precarious4. The birth 
control pill was the first prescribed form of medicine designed to be used daily by 
those who were not sick (Marks, 2001).  
 
A key political figure in the history and ultimate development of HC’s was 
Margaret Sanger, an American nurse and activist for women’s rights. Sanger 
befriended Katherine McCormick a wealthy educated woman who gave her the 
necessary financial means to pursue the development of HC’s (reviewed in Burrows 
et al., 2012). In 1941, a break came to scientists who could not afford to purchase 
expensive European synthetic hormones for research. At this time Russell Marker, 
an American chemist at Penn State, found that the wild yam, Dioscorea, of Mexico 
could be used to create large quantities of synthetic progesterone at high rates 
(Marks, 2001). Following Marker’s discovery, Sanger introduced McCormick to 
physiologist Gregory Pincus, and together with the backing of McCormick’s capital 
they then commissioned John Rock, an obstetrician and gynaecologist, to lead the 
first ever HC trials with human subjects.  
 
Eventually, G.D. Searle (where Rock was associated) became the first company to 
patent and market HC’s in 1960. The first HC, Enovid, contained 10 mg 
norethynodrel and 150µg mestranol, an astonishing dose by today’s standards 
(Edgren, 1991). Enovid had proven effective in clinical trials with 5 mg and 2.5 mg 
norethynodrel, but the Food and Drug Administration (FDA) originally denied 
approval of these lower doses for (unsubstantiated) fear of contraceptive failure 
(White Junod & Marks, 2002).5 Enovid, and the HC’s which followed, were 
initially hailed as miracle drugs. This was reflected in their rapid uptake: within five 
                                                            
4 In 1933, the Dutch company Organon permitted testing of a hormonal preparation, 
Menformon, for mitigation of menstrual issues; however, refused to test the same product as 
a contraceptive (Oudshoorn, 1994). 
5 Interestingly, prior to its release as a form of HC, Enovid had been in use for nearly 3 years 
by over nearly half a million American women as a prescription used to treat irregular 
menstrual cycles (White Junod & Marks, 2002). 
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years of their launch over 11 million women worldwide were using the pill 
(Guttmacher, 1966). HC’s transformed the way women viewed sex, freeing them of 
fears of pregnancy while allowing them to pursue education and careers. Supporters 
of HC’s also claimed they strengthened marriages through enabling sexual activity 
in the absence of the fear of pregnancy and the subsequent financial and emotional 
burden of raising an unwanted child. In the early 1960’s women began asking their 
doctors for HC’s to treat what they viewed as a medical problem (conceiving a 
child). This practice was unusual for doctors, who at the time, were used to first 
diagnosing and then dictating to patients what prescriptions they would take. It also 
revolutionized who had control of contraception. Previously, the responsibility fell 
on men to consider contraception through use of condoms or the rhythm method. 
HC’s allowed women full control over their bodies, and could be used in the 
absence of one’s partner (Marks, 2001).  
 
In spite of the initial positive appraisal, the introduction and use of HC’s was soon 
plagued with controversy. Initial possibilities of potential ties to thrombosis and to 
cancers were prominent and needed to be addressed urgently in further research 
(e.g., Donayre & Pincus, 1965; Neistadt et al., 1966; Gruenstein et al., 1964; 
Welshe & Meites, 1969). Still, many women were willing to risk these serious 
medical complications to avoid pregnancy. Coupled with the potential physical 
risks, the Catholic Church had deemed use of the pill immoral and against the will 
of God: “The moment has not come for man to entrust to his reason and his will, 
rather than to the biological rhythms of his organisms, the task of regulating birth” 
(Text of Humanae Vitae; Pope Paul VI, 1968). Opponents of HC’s also claimed use 
would generate increased promiscuity which they then feared could destroy the 
traditional family structure. It is worthwhile to note, contrary to the popular belief 
held by many, the sexual revolution of the 1960’s that followed the introduction of 
HC’s, cannot be explained due to the emergence of reliable contraception6. This is 
                                                            
6  ‘The Woodstock Generation’ of the 1960’s which is commonly associated with sexual 
openness can thus not be explained by access to reliable hormonal contraception. 
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because, in the years following the introduction of HC’s it was prescribed solely to 
married women and thus not available to young single women (Marks, 2001). In 
spite of this, the view that the introduction of HC’s resulted in sexual liberalism was 
(and remains) common. Perhaps, in fact, the relationship may be reversed: while the 
introduction of HC’s coincided with the sexual revolution, the liberalization of 
attitudes which occurred proceeding the 1960’s may have been necessary to see 
their development and the subsequent marketing. In 1953, The Kinsey Institute 
reported that over half of unmarried women had reported having (vaginal) sex - it 
seems, given this information, that the sexual revolution was well underway by the 
time that HC’s were introduced in 1960 (Kinsey et al., 1953). The sexual revolution 
may also be explained by other factors, including, for example, the uneven sex ratio 
after the war (e.g., Hesketh & Xing, 2006). The benefits afforded to married women 
who used newly introduced HC’s are highlighted in a 1975 song sung by the 
country music singer Loretta Lynn entitled ‘The Pill’ seen below.  
 
You wined me and dined me when I was your girl 
Promised if I`d be your wife you`d show me the world 
But all I`ve seen of this old world is a bed and a doctor bill 
I`m tearing down your brooder house `cause now I`ve got the pill 
 
All these years I`ve stayed at home while you had all your fun 
And every year that`s gone by another baby`s come 
There`s gonna be some changes made right here on Nursery Hill 
You`ve set this chicken your last time `cause now I`ve got the pill 
 
This old maternity dress I`ve got is going in the garbage 
The clothes I`m wearing from now on won`t take up so much yardage 
Miniskirts hotpants and a few little fancy frills 
Yeah I`m making up for all those years since I`ve got the pill 
 
I`m tired of all your crowing how you and your hens play 
While holding a couple in my arms another`s on the way 
This chicken`s done tore up her nest and I`m ready to make a deal 
And you can`t afford to turn it down `cause you know I`ve got the pill 
 
This incubator is overused because you`ve kept it filled 
The feeling good comes easy now since I`ve got the pill 
It`s getting dark it`s roosting time tonight`s too good to be real 
Aw but Daddy don`t you worry none `cause Mama`s got the pill 
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Interestingly, this song helped to access hard to reach populations of rural women in 
North America, who, upon hearing of Loretta’s song, began to take interest in HC. 
Loretta Lynn helped ‘the pill’ to gain acceptance in popular media and brought the 
discussion of issues surrounding contraception and unwanted pregnancy, which 
were initially considered unmentionable, into mainstream discussion (Sicoli, 1994).
In the 50 years that have elapsed since the introduction of the pill, substantial 
formulation changes have occurred to alleviate many of the aforementioned health 
risks while maintaining contraceptive efficiency. Today, modern HC’s contain 
different forms of synthetic hormones altogether, in far lower doses than those first 
marketed, and this has greatly reduced the occurrence of adverse physical effects. In 
spite of these changes the study of psychological side effects of HC use has still not 
yet been fully addressed. Studies to date tend to be limited to the areas of general 
mood or libido (e.g., Oinonen & Mazmanian, 2002; Sanders et al., 2001). Why 
might this be? 
Since HC’s were first introduced the political struggles associated with its 
availability have not waned, but rather simply shifted to new topics. HC is now, for 
instance, often a major political campaign issue in the Western world with views for 
and against HC’s often now seen at the heart of conflict in the Liberal-Conservative 
ideological divide7. Similarly, the Catholic Church remains a vocal proponent 
against HC’s and has therefore been a powerful force in limiting its use and access 
worldwide (e.g., Goldzieher, 1991). This suggests that HC’s remain, to some extent, 
unaccepted in society which may consequently overshadow the investigation of 
psychological side-effects.  
 
An additional possible explanation for the omission of psychological research on 
this topic is that, when HC’s were introduced, women had a deep desire to 
                                                            
7 In the most recent American presidential election Barak Obama and Mitt Romney disputed 
this topic constantly. For example, a focus of the second debate on October 16th, 2012 was on 
whether contraceptive access should be included in the healthcare bill (Tanne, 2012). 
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independently control their family size and birth intervals. In particular, HC’s 
provided ailing women with a reprieve from the impact of multiple successive 
pregnancies and lessened the economic burden of raising additional children. Many 
accounts from women who obtained some of the first prescriptions for Enovid 
suggest that they were willing to incur physical health costs in order to avoid the 
problem of unwanted pregnancy (described in Marks et al., 2001). This desperation 
may have meant that women were less likely to report subtle behavioural changes as 
they were willing to accept and cope with what were minor adjustments when 
compared to the outcome of having an additional child. This feeling may have 
amplified further during The Great Depression when extra economic constraints 
may have meant that restricting family size influenced personal survival.  
 
Now that physical side effects have lessened, women are becoming more vocal of 
potential psychological concerns associated with pill use. A quick browse through 
popular magazines and newspapers will reveal a plethora of articles on this issue. 
Recent titles such as ‘How the pill messes with women’s minds’ (Daily Mail, Oct 
20th, 2011) and ‘Does the pill affect relationships?’ (Cosmopolitan, Nov 1st, 2012) 
reflect a growing acknowledgment and interest within society of potential 
psychological effects associated with HC’s. The time has come for studies to 
investigate these anecdotal tales and determine what unrecognized psychological 
consequences may be associated with HC’s and how they might subsequently be 
mitigated.  
 
Physiology of HC’s 
 
Today contraception can be attained hormonally via orally ingested pills, via 
injections, via insertion of intrauterine devices (IUD’s), via external skin patches 
and through implanted devices (Rivera et al., 1999; Delavande, 2008). A woman’s 
choice of her preferred method of hormonal contraception is an individual decision 
based on differences in lifestyle factors. Furthermore, a woman may choose to use a 
variety of different types of HC’s at different stages of her life to meet her current 
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needs. The most common form of HC currently in use is the combined oral 
contraceptive pill, with over 100 million women worldwide currently using “the 
pill” for contraceptive purposes (Trussell, 2007). Since combined oral 
contraceptives are the most commonly used form of HC, the research contained 
within this thesis is centred on their psychological effects. Therefore, while our 
results may also apply to other forms of HC’s (e.g., injections, patches, IUD’s and 
implants), these methods were not tested within our research and will therefore not 
be described in detail here. The need to examine psychological effects of these other 
forms of administration thus remains. 
 
Alike Enovid, the first ever combined oral contraceptive pill, contemporary HC’s 
are composed of a synthetic estrogen and progesterone: ethinyl estradiol (EE) and 
progestin (South-Paul et al., 2008). A wide variety of pill types are available on the 
market and they typically vary in their progesterone component and its 
concentration, as well as the corresponding concentration of EE (Hornstein & 
Schwerin, 2013). Interestingly, there is no clear medical guideline for administering 
the variety of brands presently available on the market8. That is, there are no 
standardized criteria for prescribing one form of combined oral contraceptive over 
another form to a particular type of woman. It is common for general practitioners 
to prescribe one specific brand of combined oral contraceptive to virtually all their 
patients (typically at the advice of a drug sale representative). Should a patient 
encounter difficulties or experience negative symptoms on a particular brand they 
often undergo a period of trial and error until they find a brand which suits them 
better. It should also be noted that while hormonal profiles of women varying in 
BMI as well as ethnicity have been shown to differ (Taioli et al., 1996; Coker et al., 
1997; Randolph Jr et al., 2004) these are not factors explicitly relevant in a general 
practitioners criteria for prescribing HC’s. 
 
                                                            
8 In some countries, such as The Netherlands, where women must pay for their HC’s, the lack 
of clear guidelines often result in women simply choosing the cheapest brand available.  
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Relative to the first combined oral contraceptives today’s pills all contain very low 
doses of synthetic hormones. Current literature classifies pills with an EE dose of 20 
μg as an ‘ultra-low dose’, while a ‘low dose’ pill is typically considered to have an 
EE concentration between 30 μg and 35 μg (e.g., Poindexter, 2000; Rosenberg et 
al., 2000). Pills containing greater than 35 μg of EE are not common. There is also a 
variety of HC pills which contain no synthetic estrogen. These pills, known as 
progestin-only pills, are not typically prescribed unless patients are estrogen 
contradicted as breakthrough bleeding tends not to be as reliably controlled and 
contraceptive efficiency is more dependent upon timely administration (Amy & 
Tripathi, 2009).  
 
The most common method of administration of combined oral contraceptives is in a 
21-7 regime. In this format women swallow one pill per day for 21 days followed 
by a seven day pill free break in which they experience a withdrawal bleed. This 
format mimics the typical 28-day regular menstrual cycle. Newer versions of 
combined oral contraceptives come in formats with shorter pill free intervals. For 
example, HC pills now exist in a 24-4 regime, in which pills are swallowed for 24 
consecutive days followed by a four-day pill free interval. These regimes are 
thought to increase contraceptive efficiency while maintaining low hormone doses 
(e.g., Bachmann et al., 2004). At first glance, it may seem odd that one can vary 
regime lengths while still maintaining contraceptive efficiency. As stated 
previously, hormonal contraception was developed in an era where altering natural 
biology was considered taboo. This climate had a direct bearing on the formulation 
of the pill: researchers used a seven-day pill free interval in the initial combined oral 
contraceptives in an attempt to mimic the natural menstrual cycle and menses 
length. It was thought that this consideration would lead to the pill being viewed as 
more natural and that it would therefore gain greater acceptance from women and 
the Catholic Church (Marks, 2001)9. Typically combined oral contraceptive pills are 
                                                            
9 Today, much evidence suggests that shorter pill-free intervals (which generate shorter 
menstrual bleeds) are actually more effective (e.g., Spona et al., 1996; Sullivan et al., 1999; 
Archer et al., 2006). 
General Introduction 
Page | 31 
 
of the same dose strength each day during the pill taking phase; however, newer 
formulations such as biphasic and triphasic pills step up the dose two and three 
times, respectfully, at intervals.   
 
Combined oral contraceptives prevent fertility through a number of methods, 
though primarily they interfere with the hypothalamic-pituitary-ovarian axis. For 
instance, the estrogen component inhibits FSH production which in turn inhibits 
follicular growth. The progestin component works to actually prevent ovulation 
through inhibition of the mid-cycle LH surge (van Heusden & Fauser, 1999; Frye, 
2006). These processes suppress natural estrogen and progesterone production, 
meaning that women that use HC’s have lower serum estrogen and progesterone 












Figure 3. Pattern of estrogen (filled) and progesterone (empty) in women using low 
dose pills (diamonds) and ultra-low dose pills (triangles). Women on HC’s 
containing higher doses of hormones have their natural hormones suppressed to a 
greater extent.  
 
The progestin component also provides secondary contraceptive prevention through 
the thickening of cervical mucus and altering the endometrium making it difficult 
for sperm to penetrate into the uterus and implant (Rivera et al., 1999; Hornstein & 
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Schwerin, 2013). During the pill free interval, when the monthly menstrual bleed 
takes place, pituitary hormone activity resumes. This means that follicles begin to 
grow. Upon the initiation of the next active pill phase inhibition of growth occurs 
(van Heusden & Fauser, 1999).   
 
Given that the pituitary ovarian axis recovers function so quickly, correct pill taking 
practices are very important to ensure contraceptive protection. Pills must therefore 
be taken at the same time every day to help maintain a consistent level of hormones 
in the body, and on time after a pill free interval. Failure to do so can result in 
contraceptive failure. When taken properly, contraceptive efficiency of combined 
oral contraceptives is very high. The pearl index, a measure of contraceptive failure, 
shows that HC’s are among the most effective means of attaining reliable 
contraception.10 High levels of efficiency are typical of all of today’s HC’s (for 
comparisons with other forms of contraception see Trussell et al., 2004).  
 
In spite of successfully achieving contraceptive efficiency with lower hormone 
doses, use of even today’s most modern combined oral contraceptives is associated 
with health risks. Potential risk factors as diverse as cancers (e.g., reviewed in 
Smith et al., 2003; Kumle et al., 2002), osteoporosis (e.g., Prior et al., 2001), 
disrupted lipid and carbohydrate metabolism (e.g., Godsland et al., 1990; Klipping 
& Marr, 2005), and stroke and cardiovascular problems (e.g., Lidegaard et al., 2009; 
Baillargeon et al., 2005) have been identified and studied. Additionally, 
psychological studies have shown links to depression (e.g., Kulkarni, 2007) and 
changes in sexual function (e.g., Wallwiener et al., 2010). However, psychological 
studies conducted on HC’s have not yet adequately addressed the impact of 
contraceptive use within a wider context. Accordingly, at present a number of 
interesting questions with respect to the consequences of HC use remain 
                                                            
10 For example, in a study of Alesse, a very commonly used combined oral contraceptive, a 
Pearl index of 0.84 was reported in a study which examined over 7720 cycles in a sample of 
792 women who were tracked for six months. From this group only 5 women experienced an 
unintended pregnancy (Archer et al., 1997). 
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unanswered (Cobey & Buunk, 2012). For example: Does starting or stopping HC 
use alter the dynamic of an existing relationship?; Do women feel (and therefore 
behave) differently than they otherwise would while using hormonal 
contraception?; How might behavioural changes brought about through HC use 
impact female social relationships and well-being? In the next section I will outline 
research findings informed by an evolutionary psychology perspective that have 
attempted to answer these sorts of questions.  
 
Evolutionary psychology and HC’s  
 
Women who use HC’s do not show cyclical shifts in preferences for indicators of 
good genes or changes in their behaviour or attractiveness (reviewed in Alvergne & 
Lummaa, 2010). For example, HC users show weaker preferences for male vocal 
masculinity (Feinberg et al., 2008), no preference for either scents of symmetrical or 
asymmetrical men (Gangestad & Thornhill, 1998; Thornhill & Gangestad, 1999), 
and do not exhibit cyclical changes in perception of attractiveness as evaluated in 
voices (Pipitone & Gallup, 2008) and scent (Kuukasjärvi et al., 2004). This can be 
explained by the fact that they do not experience phases of fertility or hormonal 
shifts across the cycle (Figure 3). 
 
Such changes may impact partner choice and subsequent outcomes in relationships. 
The most compelling evidence in support of this idea comes from research on the 
major histocompatibility complex (MHC). MHC genes influence immune 
processing and are thus responsible for the recognition of foreign proteins through 
activation of T-cells (reviewed in Havlíček & Roberts, 2009). Genes of the MHC 
are highly polymorphic even within a single population and this polymorphism has 
been the centre of investigation for decades (e.g., Brown & Eklund, 1994). It has 
been argued that the maintenance of MHC variation within a population can be 
explained by a preference for MHC dissimilar partners and is therefore a product of 
sexual selection. Animal studies, typically on rodents, show support for this idea: 
individuals prefer MHC-dissimilarity in their partners (e.g., Jordan & Bruford, 
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1998; Piertney & Oliver, 2006). Selecting a partner who is MHC dissimilar means 
that resulting offspring will inherit a greater degree of MHC heterozygosity, which 
is (generally), associated with higher rates of pathogen resistance. Therefore, this 
decreases the chance that offspring will be homozygotes at a deleterious allele. 
Preferences for MHC dissimilar partners may therefore also reflect an inbreeding 
avoidance mechanism (e.g., Penn & Potts, 1999; Penn et al., 2002).  
 
MHC heterozygosity can be evaluated via odour. Wedekind and colleagues (1995) 
provided the first evidence of MHC-dissimilarity preferences in humans and on the 
subsequent effect of using HC’s on these preferences. They showed that when asked 
to rate odours obtained from T-shirts which had previously been worn by men that, 
on average, regularly cycling women rated men who were less similar in their MHC 
as more attractive. These women also stated that the scents which were less MHC 
similar reminded them more of their previous romantic partners. Interestingly, those 
women who were using HC’s rated the T-shirts of men who were more MHC-
similar as most attractive. Results therefore suggested that HC use may alter MHC 
preferences. A subsequent study by Roberts and colleagues (2008) built on this 
finding through prospectively testing MHC preferences among a sample of women 
who transitioned from regularly cycling to using HC’s. This allowed for control of 
potential between-subject differences among women using HC’s versus those who 
were non-users. Roberts and colleagues (2008) did not find a significant effect for 
MHC dissimilarity preference among regularly cycling women; however, they 
showed that after initiation of HC’s users showed a shift in preference towards 
MHC similar men. A similar shift was not observed among a control group of 
participants who did not alter HC use status. These results therefore suggest that 
HC’s may interfere with potentially adaptive human mate preferences leading users 
to choose different partners than they otherwise would. 
 
A recent study by Little and colleagues (2013) suggests this is indeed that case. 
These researchers tested masculinity preferences in a group of women prospectively 
as they transition to HC use and showed that relative preferences for masculinity 
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decreased. In a second study, they extended this laboratory based finding by 
showing that women who met their partner while using HC’s were paired with men 
who had lower levels of facial masculinity than those who met their partner while 
regularly cycling. This compelling result suggests that the absence of cyclical shifts 
in preferences has a genuine outcome on partner choice. What consequences, if any, 
this change in mate choice has on relationship dynamics or subsequent offspring 
outcomes remains to be determined.  
 
Based on the evidence that women’s preferences and attractiveness differ when 
regularly cycling as compared to when using HC’s, one might predict that initiating 
HC use within an existing relationship may cause changes in levels of satisfaction. 
Recent research by Roberts and colleagues (2012) provides preliminary support for 
this idea. They showed that women who met their partner while using HC’s 
reported to be more satisfied with their partner emotionally; however, these women 
reported lower sexual satisfaction with their partner (controlling for current pill use) 
than women who met their partner off of the pill. This may be explained in relation 
to the framework of Little and colleagues (2013) who provide evidence that women 
on HC’s are paired with less masculine (i.e., more investing) men.  
 
The brevity of this section relative to the section of cyclical shifts across the 
menstrual cycle accurately reflects the current state of literature on this topic: little 
is known about HC effects on mate choice and social relationships. There are 
several possible reasons why this may be the case. I have previously discussed the 
idea that women may have been willing to accept psychological symptoms in order 
to prevent pregnancy or how physical symptoms may have overshadowed 
psychological ones. However, practically speaking the cost of conducting this sort 
of psychological research presents a further barrier. Additionally, while researchers 
would ideally track large groups of women’s romantic and social relationships 
longitudinally as they switch on and off the pill, there are both medical and ethical 
concerns in assigning women to use HC’s (as well as placebos) which must be 
considered. As a result of these practical limitations, research conducted to date, on 
General Introduction 
 
Page | 36 
 
psychological effects of HC, with few exceptions, typically makes use of between-
subject samples in which women using the pill are compared to women not using 
the pill on a variety of dimensions. This is, of course, not a rigid means to 
sufficiently test the questions at hand, and therefore herein I intended to improve (to 
the extent it was possible) upon the typical methodological shortcomings of 




The empirical work contained within this thesis has been structured in two parts 
which I now provide a summary of. Part One investigates HC and menstrual cycle 
effects on female romantic jealousy. Part Two of this thesis attempts to 
contextualize the findings documented in Part One with respect to jealousy. In this 
latter section I present research investigating intrasexual competition and 




In Chapter Two, I present results from a study that examined the effect of HC’s and 
the menstrual cycle on female jealousy. This study is unique to the literature in that 
it is one of the first studies in this area to be conducted using a within-subjects 
design in which the same women are tested when they are regularly cycling and 
using HC’s. Similarly, it uses transvaginal ultrasonography to detect fertility status 
as opposed to one of the more crude methods (e.g., forward counting from onset of 
menses) that are typically employed in this line of work. At the outset of this 
research the prevalent view within the literature was that female jealousy increased 
when a woman was fertile as compared to non-fertile and similarly that jealousy is 
higher among women using the pill than among women who were regularly cycling 
(Geary et al., 2001). However, as all studies to date were conducted using between-
subjects samples, a study using a within-subjects design remained necessary to 
validate these findings. In line with previous research I predicted that when sampled 
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within-subjects women would report higher levels of jealousy when fertile as 
compared to non-fertile. In addition, I predicted that HC use would be associated 
with higher levels of jealousy than when regularly cycling since estrogen, which is 
greatly suppressed by synthetic hormones during use, has been shown to be 
intimately related to emotional behavioural outcomes (Fink et al., 1995; Steiner et 
al., 2003). 
 
In Chapter Three, I present a cross-cultural study which examined the influence of 
female menstrual cycle stage on jealousy response. This study aimed to replicate a 
portion of the results presented in Chapter Two, that is, that women experience 
higher levels of jealousy when fertile than when non-fertile. The study is unique to 
the literature in that it is one of the first studies to my knowledge which examines 
menstrual cycle effects on female behaviour in an African Caribbean sample. 
Moreover, this study also benefited from the use of a relatively older population of 
women of which many were non-students. I predicted that, while baseline levels of 
jealousy may differ in this population, Curaçao women would report higher levels 
of jealousy when fertile than when non-fertile.    
 
In Chapter Four, I present a study which more closely examines the effect of HC 
use on female jealousy. In Chapter Two, I tested overall effects of HC use on 
jealousy and found, among other results, that women report higher levels of 
jealousy when using the pill as compared to when non-fertile. In Chapter Four, I 
assessed how specific HC formulations might differentially influence female 
jealousy. Based on the fact that combined HC’s come in different doses I examined 
whether higher concentrations of synthetic hormones in the pill were associated 
with higher levels of jealousy. I predicted that the higher concentrations of synthetic 
estrogen, known to suppress natural female estrogen, would invoke greater levels of 
jealousy. I also tested for effects of synthetic progesterone concentration, since 
some evidence has shown that progesterone regulates affiliation behaviour (e.g., 
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In Chapter Five, I present results of a study which examined how jealousy within 
romantic relationships may be influenced by different contexts of HC use. 
Specifically, I examined how congruency between present use/non-use of HC’s and 
use/non-use at the start of the relationship might influence current levels of 
jealousy. This study was derived from research which indicates that female mate 
preferences change when women initiate HC’s (reviewed in Alvergne & Lummaa, 
2010). Based on this, I expected that if a woman chose her partner when she was 
not using HC’s and then later began use, she may find that her new preferences are 
no longer satisfied by her mate and subsequently express jealousy in reaction to her 
relationship uncertainty. To do this, I examined the independent effect of current 
contraceptive use, contraceptive use at the start of the relationship and the 
congruency between current use and use at the start of the relationship of levels of 
jealousy. I predicted that in instances where current contraceptive use was 
incongruent to use at the start of the relationship, levels of relationship jealousy 





The motivation for Part Two of this thesis came from critical evaluation of specific 
findings obtained in Part One. In Part One we found that women reported increased 
jealousy when fertile as compared to when non-fertile (Chapter Two and Chapter 
Three). However, it is not directly obvious why this might be: expressing jealousy 
when fertile is not likely to aid women in siring more children or children of better 
quality and it certainly does not appear that such shifts would be overtly linked to 
survivorship. Based on this, I aimed to conduct a series of studies in Part Two 
which more directly specified the underlying processes involved in increased 
jealousy when fertile. This was done in an effort to augment my explanation of the 
mechanism behind the findings. I sought to examine other factors which are likely 
to be related to jealousy or which jealousy may be a by-product of. I tested if 
intrasexual (same-sex) competition or self-perceptions of attractiveness varied 
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across the menstrual cycle. Shifts in competitive behaviour or competitive ability 
can be understood as directly advantageous to fitness and may therefore contribute 
to shifts in jealousy. 
 
In Chapter Six, I present the results of a study which considered shifts in intrasexual 
competition across the menstrual cycle and during use of HC’s. As in Chapter 2, 
this study used a within-subjects design and transvaginal ultrasonography to assess 
fertility. Here, I predicted that levels of intrasexual competition would be higher 
when fertile than when non-fertile as in Fisher (2004). Also, speculatively, based on 
the assumption that intrasexual competition may relate to jealousy, I predicted that 
during HC use levels of intrasexual competition would be higher. As you read on, 
you will see that the results of this study diverged a great deal from these 
predictions, and I will discuss why this might be the case and what explanation I put 
forward for the initially unexpected findings.  
 
In Chapter Seven, I present a study on self-perceived attractiveness across the 
menstrual cycle and during use of HC’s. Again, as in Chapter Two and Chapter Six, 
this study used a within-subjects design. However, in this study I also tracked 
female participant’s male partners when the women were both regularly cycling and 
using HC’s. I had no concrete predictions for the anticipated direction of shift of 
self-perceived attractiveness among women because previous results have indicated 
both positive and negative self-evaluations when fertile as compared to non-fertile 
(e.g., Haselton & Gangestad, 2006; Hill & Durante, 2009). However, I predicted 
that should females indicate a shift in their attractiveness at any of their measures, 
male self-reports would shift in the same direction. You will see that these 
predictions also did not hold, again failing to provide a mechanism for cyclical 
shifts in jealousy. However, results provide other important insights into the impact 
of fertility status on relationship dynamics. To finish, in Chapter Nine I will re-
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Previous research suggests that female jealousy is sensitive to hormonal 
variation and, more specifically, potentially moderated by estrogen levels. 
Here, we tracked self-reported jealousy using a within-subjects design, 
comparing jealousy when the same women were regularly cycling and using 
hormonal contraceptives. Results show that fertile cycle phases are associated 
with higher levels of jealousy than non-fertile cycle phases in both single and 
partnered women. However, patterns of jealousy reported when using 
hormonal contraceptives, as compared to when regularly cycling, differed 
between single and partnered women. In single women, levels of jealousy while 
on the pill fell between those reported when fertile and non-fertile but were not 
significantly different from either. In partnered women, levels of jealousy while 
using the pill were significantly higher than those reported during the non-
fertile cycle phase and similar to those during the brief period of fertility. We 
discuss possible reasons for differences between single and partnered women in 
reported jealousy while using the pill. This research is among the first to 
definitively show that a psychological characteristic, for example, jealousy, 
may be influenced differentially by endogenous hormones vs. exogenous 
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A growing body of literature suggests that women have evolved subtle changes in 
behaviour and preferences across the menstrual cycle as a function of conception 
risk (e.g., Penton-Voak et al., 1999; Jones et al., 2008). To reiterate from the general 
introduction many of these studies focus on testing cyclical shifts in preferences for 
indicators of male genetic quality (reviewed in Garver-Apgar, Gangestad & 
Thornhill, 2008). For example, masculinity and body odour are argued to function 
as honest signals of health (e.g., Thornhill & Gangestad, 1999; Roberts et al., 2005; 
but see also Getty, 2002). Female attraction towards these good gene traits is said to 
increase during fertile phases of the cycle because during this time obtaining genetic 
benefits for future offspring is most relevant (e.g., Thornhill & Gangestad, 1999).  
Research has also documented shifts in female attractiveness across the menstrual 
cycle. For instance, female faces (Roberts et al., 2004), voices (Pipitone et al., 
2008), and choice of dress (Haselton et al., 2007) are judged to be most attractive 
when women are at fertile cycle stages. Heightened attractiveness during fertility 
could be seen as adaptive as it may allow women to attract a larger pool of potential 
partners, or partners of higher quality, when conception risk is highest. Evidence 
indicating that men show increased mate guarding towards fecund female partners 
suggests that menstrual shifts in attractiveness have consequences for male 
behaviour as well (Gangestad et al., 2002; Flinn, 1988). Similarly, the literature 
suggests that male mate guarding of fecund partners is moderated by female 
attractiveness: with more attractive women experiencing higher degrees of mate 
guarding (Haselton & Gangestad, 2006). In line with these findings, women in 
relationships, particularly those who assess their male partner not to have good 
genes traits, are more likely to report extra-pair flirtation when fertile. 
 
Taken together the plethora of recent studies documenting female menstrual cycle 
shifts prompts a key question: do cyclical shifts in preferences or behaviour have an 
adaptive function? If this reasoning is correct, then use of HC’s, which suppress 
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cyclical variation, may lead to less adaptive mate preferences and behaviours than 
those found within non-users.  
 
Indeed, there is some evidence in support of this notion. Relative to non-users, 
women who use HC’s demonstrate decreased preferences for indicators of genetic 
quality in males (e.g., Little et al., 2002; Roberts et al., 2008; Wedekind et al., 1995) 
and overall decreased attractiveness in their behaviour (Miller et al., 2007). If 
menstrual cycle shifts play a meaningful role in allowing women to select quality 
partners or to obtain, attract, or retain mates, then the use of hormonal contraception 
may have consequences for the selection of new partners as well as for the stability 
of existing pair bonds (Alvergne & Lummaa, 2010; Roberts et al., 2012).  
 
Apart from influencing partner preferences and attractiveness, research also 
suggests that HC use and menstrual cycle shifts in hormones may influence 
relationship jealousy. Relationship jealousy can be defined as thoughts, emotions, 
or behaviours which occur as a result of the perceived threat of losing a potential 
mate to an actual or imagined rival (Buunk, 1991). Jealousy can be adaptive in that 
it allows women to monitor their partner and to foresee any potential threats to her 
monopolization of his resources or direct paternal care. Using a within-subjects 
design Geary and colleagues (2001) correlated estimated levels of estrogen in 
regularly cycling women to jealousy. While they found no mean differences in 
jealousy scores across cycle weeks, relative periods of high estrogen (increased 
conception risk) in week two of the cycle were associated with higher levels of 
jealousy. The benefit of cyclical shifts in jealousy is not entirely clear. Geary and 
colleagues (2001) hypothesized that this finding might be explained as a result of 
increased sexual desire during times of high estrogen. It remains an empirical 
question as to whether such shifts in jealousy are adaptive, or if they are indeed a 
by-product of other processes such as sexual desire. In a second study Geary and 
colleagues (2001) reported that women who used oral contraceptives had higher 
levels of sexual jealousy than non-users. Taken together, these findings suggest a 
role for estrogen in female jealousy responses. 
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Using a within-subjects design I test how female relationship jealousy varies, firstly 
as a function of fertility status across the menstrual cycle, and secondly as 
influenced by the use of HC’s. The vast majority of research on pill-induced 
behavioural effects, including that of Geary and colleagues (2001), is limited by the 
fact that it draws conclusions based on between-subjects designs. The use of 
between-subjects designs is problematic in that there may be pre-existing 
differences in culture, personality, sexual experience, relationship status, socio-
economic status, and conscientiousness between those women who choose to use 
hormonal contraception and those who do not (Roberts et al., 2008; Alvergne & 
Lummaa, 2010). To address these methodological issues, here I use a within-
subjects design in which participants are tracked both while they are regularly 
cycling and after they have commenced oral contraceptive use.  
 
This study also benefits from an accurate process of detecting, and therefore 
defining, periods of fertility. Previous menstrual cycle studies have typically made 
crude estimates of the timing of ovulation, in many instances relying on female self-
reports of menstrual onset, from which researchers count forward or backwards to 
establish an estimate of fertility. Beyond the potential for errors in self-report, the 
timeframe for which fertility is defined is highly inconsistent across studies (e.g., 
backward counting to day fifteen, Garver-Apgar et al., 2008; forward counting to 
days nine-fifteen, Miller et al., 2007; forward counting to days six-fourteen, Penton-
Voak & Perrett, 2000). More recently, luteinizing hormone (LH) test strips have 
been used in an effort to better estimate fertility (e.g., Pillsworth & Haselton, 2006). 
However, this method is limited by the fact that it fails to account for anovulatory 
cycles in which luteinized follicles remain unruptured (Metcalf & Mackenzie, 1980; 
Qublan et al., 2006). Further, there is variation in the definition of the duration and 
timing of the fertile period with reference to the detection of an LH surge (e.g., one 
day prior and five days after, Gangestad et al., 2002; two days prior and three days 
after, Haselton et al., 2007). Use of transvaginal ultrasonography allowed us to 
improve on this aspect of previous research.     
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Based on previous results reported by Geary et al., (2001) I predicted that, when 
regularly cycling, fertility (e.g., phases relatively high estrogen), will be associated 
with significantly higher levels of jealousy relative to the non-fertile cycle stage. 
Similarly, based on previous research I predicted that HC use would be associated 





Participants were twenty-nine females of white European descent aged between 20 
and 33 (M = 22.59 years; SD = 2.63 years). Participants were taking part in one of 
two clinical drug trials that tracked the inhibition of ovulation when using HC’s. 
Participants were not given placebos or any other medication during their 
participation in either of the trials. Both trials had been ethically approved by an 
independent medical ethics committee. Criteria for participant exclusion included: 
pregnancy, lactation, irregular menstruation (cycle length greater than forty-two 
days), a history of drug or alcohol abuse, the use of depot progestogen preparations, 
injectables, or biodegradable implants (within the past six months), clinically 
relevant abnormal cytology within the past three years as assessed by a cervical 
smear, or clinically significant abnormalities in routine hematology, serum 
biochemistry, and urinalysis at screening.   
 
Women were recruited for the purpose of the present study via advertisements and 
word of mouth. This research was approved by the University of Groningen Ethics 
Committee. Participants were paid for their participation, or alternatively, entered 
into a draw to win an iPhone (or its equivalent in monetary value) in compensation 
for their time taking part. Of those who chose to take part, thirteen women were 
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Measures 
The study consisted of three sessions: two that occurred when participants were 
regularly cycling (first at a high and then at a low-fertility period) and one when 
participants were using HC’s. During each of the three scheduled sessions 
participants were asked to complete a computer-based survey. Seventeen of the 
participants, those recruited from trial one, completed the surveys on their home 
computer. They were specifically instructed to complete the online survey in private 
and in the absence of potential distractions. The remaining twelve participants, 
those who were recruited from the second trial, completed their surveys on a PC in 
a laboratory of a Psychology Department at a large European University.  
 
The survey was completed in Dutch (by native Dutch speakers) and contained basic 
demographic measures and the original Dutch version of a Jealousy Scale (Buunk, 
1997) (Cronbach’s alphas = .86 (fertile), .89 (non-fertile), .87 (pill use)). This is a 
fifteen-item questionnaire in which answers are reported on a one to five scale with 
higher scores indicating higher levels of jealousy. Example items include: “I am 
concerned that my partner finds someone else more attractive than me”, “It is 
unacceptable to me that my partner has friends of the opposite sex”; “How would 
you feel if your partner would dance intimately with someone of the opposite sex?”.  
 
 
Session Scheduling   
To accurately schedule participants for their three sessions each individual was 
tracked for a period of at least four months. Participants were tracked for one month 
while spontaneously cycling. Participants who had been using HC’s underwent a 
washout cycle in which no measurements were taken prior to being observed for a 
full menstrual cycle. Previous research has shown that hormone levels return to 
baseline well before two months after ceasing contraceptive use (e.g., Duijkers et 
al., 2005). Ovarian function is restored within a few days of stopping HC’s. 
Moreover, ethinyl estradiol and progestogens have half-lives of ten hours and eight 
to twenty-four hours respectfully, and will thus have been eliminated well before we 
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took our regularly cycling measures (Goldzieher, 1989; Täuber, Tack & Matthes, 
1989).   
 
During this time participants underwent transvaginal ultrasonography (GE Voluson 
E8 device, with a 4-8 MHz vaginal transducer) readings every 3 ±1 days, starting on 
day nine of the menstrual cycle, to determine their proximity to ovulation. As 
indicated in Duijkers et al., (2004) follicles were measured in two directions and a 
mean size was calculated. Participants were instructed to complete their ‘fertile’ 
survey within 48 hours of their regular transvaginal ultrasonography measurements 
indicating that they had a follicle that was greater than or equal to 13 mm in size, 
demonstrating that the dominant follicle had developed, and therefore the fertile 
phase was entered. We then continued to monitor participants via transvaginal 
ultrasonography to ensure that ovulation took place. Fertility was also confirmed by 
the measurement of serum progesterone levels. In line with Hoogland and Skouby’s 
(1993) classification system for measuring ovarian activity using ultrasound 
technology, all participants were observed to have a progesterone level greater than 
5nmol/L at the time they completed their fertile survey. According to the Hoogland 
scoring system this indicates either a luteinized follicle or a ruptured follicle 
suggesting that risk of conception is high.  
 
The second survey, the ‘non-fertile’ survey measure, was completed during the 
luteal cycle phase. Participants were instructed to complete this survey six days or 
more after it had been observed, via transvaginal ultrasonography, that they had 
ovulated. For the purpose of the HC survey, participants had to have been using 
contraceptives for a minimum duration of three months. Participants were using a 
wide variety of different brands of combined oral contraceptives all of which were 
low dose formulations administered through a twenty-eight day regime with twenty-
one days of active pills followed by a seven-day pill free week. Participants 
completed the ‘pill use survey’ on an active pill day at least fifteen days into the 
third month of consistent HC use.  
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The order in which the surveys were administered was not completely randomized, 
as this was constrained by the clinical trial. However there was, variation in the 
order of completion based on which of the two trials participants were recruited 
from. Twelve women completed the surveys in the order ‘pill use survey’, ‘fertile 
survey’, ‘non-fertile survey’; while, seventeen women completed the surveys in the 
order ‘fertile survey’, ‘non-fertile survey’, ‘pill use survey’. 
 
Data Analysis 
Results were analyzed using hierarchical linear mixed modeling (SPSS, 15.0) with 
measurements nested for each subject. Data was log transformed to obtain a normal 
distribution (Raw data: skewness statistic: 1.06, SE = .26; Transformed data 
skewness: .363, SE = .26). Results reported are consistent to those found when 
analysed with the non-transformed data.  
 
I first analysed the model with jealousy as the dependent variable, fertility status 
(fertile, non-fertile, pill use), relationship status, and the order in which participants 
completed their surveys as fixed factors, and age as a covariate. I also included the 
interaction of fertility status and relationship status in this model. Parameters were 
estimated by Maximum Likelihood and the model had absolute convergence in 
terms of loglikelihood, parameter and Hessian convergence. A random intercept 
was included at participant level. I report F-test and t-tests for the post-hoc 
comparisons. After this overall model, I report the same test conducted 




The overall model indicated a significant effect of fertility status of jealousy scores 
(F (2, 58) = 4.02, p = .02). Relationship status, order surveys were competed in, and 
the interaction of fertility and relationship status were all non-significant (all F < 
2.81, all p > .26). Age had a marginal influence on the model (.10). Pairwise 
comparisons revealed that levels of jealousy reported when fertile were significantly 
Jealousy increases when fertile and when using HC’s 
 
Page | 50 
 
higher than those reported when non-fertile (Mean difference = .068, SE = .026, p = 
.01). Levels of jealousy reported when using the pill were not significantly different 
from those reported when fertile (Mean difference = -.013, SE = .026, p = .61) but 
were significantly higher than those found when non-fertile (Mean difference = 
.055, SE = .026, p = .035).  
 
A priori relationships status was considered to be an important factor which may 
differentially influence the expression of jealousy. Therefore, although the 
interaction between fertility status and relationship status in the overall model was 
non-significant, given our small sample size I chose to consider single and 
partnered women distinctly. When analyzed in individual tests, results for single 
and partnered women differed somewhat in spite of the non-significant interaction 
between fertility status and relationship status in the overall model (see Figure 4). 
Among single women jealousy scores were significantly higher when fertile than 
non-fertile (Mean difference = .074, SE = .035, p = .04); however, there was no 
difference between levels of jealousy reported when regularly cycling and when 
using the pill (fertile versus pill: Mean difference = .053, SE = .035, p = .14; non-
fertile versus pill: Mean difference = -.021, SE = .035, p = .55). Similarly, although 
marginally significant, among partnered women levels of jealousy were higher 
when fertile than non-fertile (Mean difference = .063, SE = .037, p = .10). However, 
levels of jealousy reported by partnered women were higher when using the pill 
than when non-fertile (Mean difference = .089, SE = .037, p = .02), but not different 
when using the pill versus being fertile (Mean difference = .026, SE = .037, p = 
.48). In neither the model for single or partnered women was there a significant 
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Figure 4. Mean jealousy scores (+SE) for women across survey measures. (a) 
Single women reported significantly higher jealousy when fertile as compared to 
non-fertile. (b) Partnered women reported marginally significantly higher levels of 
jealousy when fertile as compared to non-fertile. Levels of jealousy when on the pill 
were significantly higher than when non-fertile. 
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Via a within-subjects design I investigated if self-reported female jealousy varies 
across the menstrual cycle and what effect HC pill use had on this behaviour. 
Results indicate that jealousy varies as a function of menstrual phase, with higher 
levels of jealousy reported when fertile than when non-fertile in both single and 
partnered women. To date, research documenting cyclical effects in behaviour and 
preferences is typically framed within the ovulatory shift hypothesis (e.g., Durante 
et al., 2008; Gangestad et al., 2004). The ovulatory shift hypothesis argues that 
women can benefit from engaging in extra-pair sex to obtain genetic benefits for 
offspring, but that this comes at a cost of potentially losing a long-term partner. 
Therefore, selection is assumed to have shaped women to express pronounced 
preferences for genetic indicators in men that they evaluate as short-term sex 
partners only when conception risk is high (Gangestad & Thornhill, 1998; 
Gangestad et al., 2002). While substantial evidence exists in support of the 
ovulatory shift hypothesis, I do not feel the present results are best explained within 
this framework. 
 
While I believe jealousy may be adaptive to ensure monopolization of partner 
resources and paternal care, I do not see how cyclical shifts in jealousy could be 
advantageous to women. That is to say, the size of potential threats in a relationship 
does not differ for women when fertile versus non-fertile. In men it is clear that 
shifts in jealousy with respect to partner fertility serve an adaptive function. Given 
the fitness loss associated with cuckoldry, and the high cost (e.g., time) of 
remaining vigilant of one’s partner at all times, it is adaptive for men to display 
more jealousy during times when female conception is possible. By contrast, for 
women, who risk being deserted by their partner and left with the burden of 
parenting in the absence of male resource investment, the costs of jealousy are equal 
irrespective of fertility status. Moreover, our findings seem at odds with previous 
literature on cyclical effects which suggests that fertile periods are associated with 
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increased extra-pair interest rather than fear of partner infidelity (e.g., Jones et al., 
2005; Pillsworth & Haselton, 2006). 
 
For a trait to be considered an adaption it must enhance the fitness of its possessor 
relative to individuals that do not possess the trait. There is no reason to believe that 
women who possess strong cyclical shifts in jealousy gain a fitness benefit. 
Likewise, it is unlikely that in the absence of cyclical variability in jealousy women 
would suffer a fitness disadvantage and sire fewer offspring. However, it may be 
that our scale for jealousy taps into some other aspect of mate choice processes 
which is indeed adaptive. For example, jealousy may be involved in the process of 
selecting and competing to obtain a mate. Previous research has shown that women 
increase levels of female-female competition when fertile (Fisher, 2004). Such 
shifts are adaptive in that they allow women to obtain a partner of higher quality 
than they otherwise would. It may be that women find themselves feeling more 
jealous when fertile because mating competition is most salient at this time. A 
limitation to our study is that the items on the scale used to measure jealousy are 
specific to a real or imagined partner. It may be that overall levels of jealousy, or 
specifically jealousy towards attractive females, are driving the effects I report. 
Future research is needed to explore this hypothesis.  
 
Geary and colleagues (2001) suggested a possible explanation for cyclical shifts in 
jealousy is that they are a by-product of higher levels of sexual desire when fertile 
as compared to when non-fertile. This does not appear to be an entirely consistent 
explanation for our results as it has previously been shown that HC use lowers 
overall levels of sexual desire (e.g., Graham & Sherwin, 1993). Our finding among 
partnered women which shows that levels of jealousy are similar when fertile and 
when using HC’s suggests that levels of sexual desire are not likely to explain our 
effects unless the relationship between the two variables is more complex.   
 
One might also argue that female shifts in jealousy are a by-product of male shifts 
in jealousy. That is to say, women may respond to increases in partnered male 
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jealousy through increasing their own expression of jealousy. This however, 
appears not to be an adequate explanation given that I find similar effects among 
single and partnered women. Given that both single and partnered women shift 
levels of jealousy across the menstrual cycle suggests that this shift is unlikely to be 
adaptive as it would be costly to evoke in situations which are not appropriate. At 
this stage it is difficult to specify a strong causal interpretation of what cyclical 
variation in jealousy may be a by-product of. Nonetheless, I find that periods of 
high estrogen are associated with higher affective responses to partner jealousy, a 
finding which is consistent with previously reported data (Geary et al., 2001).   
Two important implications arise from our results. Firstly, the demonstration that 
there are clear temporal changes in jealousy across the menstrual cycle in both men 
and women hints that fertility may correspond to periods of relationship conflict. 
Future research in which couples are tracked on features such as relationship 
satisfaction and jealousy across the menstrual cycle may help to disentangle 
temporal changes in jealousy even further. Secondly, I show that among partnered 
women HC use increases levels of jealousy from the non-fertile baseline which 
occurs across the menstrual cycle. Higher overall levels of jealousy in women on 
the pill may have negative consequences on their relationships, but also perhaps on 
self-esteem and upon overall individual wellbeing. That I only find a pill effect 
among partnered women may suggest that pill use initiation has altered the 
dynamics of the partnership, causing increased tension between partners. Men may 
be responding to changes in their female partner, which occur as a result of 
contraceptive use, causing jealousy among women. Future work is needed to 
explore the real world implications of these findings in more detail. It remains an 
empirical question as to whether or not the shifts in jealousy documented are indeed 
noticeable to male partners, and if or how they might influence relationship 
dynamics, or levels of male partner investment.    
 
There are several limitations to our findings. Firstly, our design was not fully 
randomized. Future research should aim to completely randomize the fertile, non-
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fertile, and pill measures, so as to avoid the possibility of any order effects. Further, 
as alluded to previously, the scale I used to asses jealousy asked participants to 
respond to items that required them to imagine their partner in a variety of different 
contexts. Our study included both single and partnered women. Research conducted 
within the Netherlands shows that 91% of Dutch individuals between the ages of 
20-24 report having had at least one romantic relationship (De Graaf et al., 2005). 
While I feel it is unlikely (mean age: 22.59 years), it is possible that single women 
in our sample have no previous relationship experience. Alternatively, women who 
were recently partnered may have been better able to imagine how they would react 
to the scale items than those who have been single for a longer period of time. It is 
therefore somewhat unclear how single women answered the jealousy questions. 
For example, I do not know whether they were imagining a love rival for a current 
love interest or recalling a love rival. Future research should seek to collect 
information with respect to previous partnerships to account for these limitations. 
 
As they stand, our results suggest that jealousy may be influenced differentially by 
endogenous and exogenous hormones. Yet, it is difficult to specifically distinguish 
between the effects of the hormones contained within HC’s, and the resulting effect 
of suppressing natural hormones. What is clear is that there may be more variables 
than often assumed that are involved in explaining cyclical shifts as well as HC-
induced behavioural changes. Future research on this topic could consider the 
effects of HC use based on differences in concentrations or derivative forms of 
synthetic hormones used (see Chapter Four). Finally, our study is limited by the fact 
that participants chose to take part in a clinical trial and may therefore differ in 
some way from women within the general population. Although participants were 
unaware of the predictions of the study, they may have been cognizant of the fact 
that I was interested in HC induced behavioural changes. A future study using a 
double-blind placebo control design could get around this issue (see for example 
Yonkers et al., 2005). 
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In summary, this study shows that regularly cycling women report higher levels of 
jealousy during fertile phases as compared to non-fertile phases, and it indicates that 
use of HC’s results in significantly higher absolute levels of jealousy than when 
non-fertile. If either temporal shifts in jealousy or increased baseline levels of 
jealousy have consequences on relationship quality or mate choice, then use of 
HC’s may be disrupting these processes.   
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Abstract 
The vast majority of literature which has tested for changes in female behavior 
and mating preference across the menstrual cycle has been conducted using 
student samples comprised of largely white undergrads from Western 
populations. The present study examined cyclical shifts in female jealousy 
among a sample of 71 African-Caribbean women from Curaçao. Results 
suggest, in line with previous findings, that women experience higher levels of 
relationship jealousy when fertile as compared to when non-fertile. We discuss 
possible explanations for the usefulness of cyclical shifts in jealousy in context 
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As we have seen from the Introduction and Chapter Two, a great deal of literature, 
from both human and non-human species, has provided evidence that female mating 
preferences and behaviour are systematically influenced by fertility status. Among 
humans, several studies have shown that women are rated as more attractive when 
fertile than when non-fertile: males indicate a stronger preference for fertile female 
faces (Roberts et al., 2004), voices (Pipitone & Gallup, 2008; Bryant & Haselton, 
2009), and scents (Singh & Bronstad, 2001; Havlíček et al., 2006; Gildersleeve et 
al., 2012). In addition to shifts in attractiveness, heightened female attraction to 
‘good gene’ males and increased sexual interest are known to occur during fertile 
phases of the menstrual cycle (reviewed in Gangestad & Thornhill, 1998). Women 
have been shown to prefer increased facial masculinity (Penton-Voak et al., 1999; 
Penton-Voak & Perrett, 2000), vocal masculinity (Puts, 2005; Feinberg et al., 2006) 
and more dominant male scents (Havlíček et al., 2005) during fertility. Increased 
fertile preference for non-physical traits, including preferences for dominant male 
behaviour (Gangestad et al., 2004), creativity (Haselton & Miller, 2006), and 
intelligent appearance (Gangestad et al., 2007) have likewise been documented. 
 
What survival value or reproductive advantages lie in such shifts? As described in 
the General Introduction, changes in female preferences and mating behaviour 
across the menstrual cycle are typically explained within the framework of the 
ovulatory shift hypothesis (Gangestad & Thornhill, 1998; Gangestad & Thornhill, 
2008). The ovulatory shift hypothesis is based on two primary assumptions: (1) that 
the risk or cost of being abandoned by ones male partner is consistent across the 
cycle, but that (2) the potential benefits of extra-pair sex are higher when fertile as 
compared to when non-fertile. Accordingly, this theory posits that women may 
benefit from employing a mixed strategy in which they selectively seek out extra-
pair copulations (with high quality partners) when fertile, but not when non-fertile 
since in general men of high genetic quality tend to be less inclined to invest 
paternal effort than are men who are of comparably lower quality (Gangestad & 
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Thornhill, 2008). As a result, greater sexual interest during times of fertility is 
explained as an adaptation which allows women to pair with a partner they 
otherwise could not obtain or from whom resource investment would be unlikely. 
 
As in Chapter Two, the present research investigated menstrual cycle shifts in 
female jealousy. Before delving into the methods of this study, I will first expand on 
the previous discussion of jealousy. Recall that jealousy is a basic human affect that 
is aroused in situations where there is a loss, or perception of a potential threat to 
lose, a valuable relationship (Symons, 1979; Daly et al., 1982; Buunk et al., 1996). 
The experience of jealousy in such situations subsequently motivates behaviour that 
aims to thwart potential losses. Previous research has shown that jealousy is 
experienced differently for men and women (e.g., Buss et al., 1992; Buunk et al., 
1996). That is, the triggers for both psychological and physical jealousy vary 
between the sexes. For example, when asked to report whether a mate’s sexual or 
emotional infidelity would be more upsetting, women are more likely to report 
greater upset to emotional infidelity, while men are more likely to report greater 
upset to sexual infidelity (e.g., Buss et al., 1992; Buunk et al., 1996; Buss et al., 
1999; Wiederman and Kendall, 1999; Pietrzak et al., 2002; Sagarin et al., 2003; 
Schützwohl, 2007). Moreover, participants of both sexes who choose these 
respective forms of infidelity as most upsetting were quicker to make this decision 
than are those who choose the reverse (Schützwohl, 2005). Sex differences in 
jealousy can be explained as the result of differences in parental certainty (Trivers, 
1972). For example, unlike women who bare the reproductive cost of gestation, 
men have no paternal certainty. As such, a woman’s sexual infidelity may burden 
her male partner into investing in an unrelated child. Given that investing in non-kin 
is costly in terms of time and resources, it is alleged that men who successfully 
attend to and thwart off potential incidences of female infidelity would have higher 
reproductive success than those who do not. It has been asserted that male sexual 
jealousy evolved to solve this adaptive problem (Daly et al., 1982; Buss et al., 
1992). Previous research which has shown that women report increased mate 
guarding from their male partners when fertile supports this idea (Gangestad et al., 
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2002; Flinn, 1988). Further, male mate guarding of partners during fecund periods 
has been shown to be moderated by female attractiveness: with more attractive 
women experiencing higher degrees of mate guarding (Haselton & Gangestad, 
2006).  
 
Females face a different adaptive problem. The cost of raising an infant is 
substantially higher in the absence of bi-parental investment (Alexander & Noonan, 
1979). Accordingly, a man’s sexual infidelity poses the risk that a woman may be 
abandoned by her partner who begins to invest in pursuing a new woman, or 
alternatively, siring and investing in new offspring. Such loss of investment is 
particularly costly to women in environments where investment from only one 
parent may incur survival costs to children. As a result, females are particularly 
threatened by the possibility that their partner will leave them for someone else. 
However, as set forth in the ovulatory shift hypothesis and discussed in Chapter 
Two, this loss is of equal significance irrespective of fertility status. That is, the 
costs of losing one’s partner or them siring another woman’s child, does not differ 
for a woman when fertile versus non-fertile. In spite of this, a variety of findings 
suggest that levels of relationship jealousy reliably fluctuate across the menstrual 
cycle. The first to address this potential was the work of Gaulin and colleagues 
(1997) who, using between-subjects design, showed that estrogen levels, but not 
progesterone levels, were positively correlated with female jealousy response. In an 
extension of this work, Geary and colleagues (2001) later showed that jealousy 
response correlated with measured estrogen concentration in cycle week two. This 
suggests that periods of high fertility are associated with increased levels of 
jealousy. In Chapter Two I found the same pattern of results using a within-subjects 
sample from a Dutch population. This study was unique in that it examined cyclical 
shifts in jealousy among single and partnered women separately. Interestingly, the 
degree of shift in jealousy documented was larger among single women than among 
partnered women.  
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The function of increased jealousy during fertility is not however directly obvious. 
It is possible that jealousy is a manifestation of increased levels of intrasexual 
competition (this is tested in Chapter Six). Previous research has shown that women 
are more intrasexually competitive when fertile (Fisher, 2004) suggesting that 
fertility may be a time where competition for mates is more salient. Accordingly, 
jealousy may increase as a consequence of the fact that women are more conscious 
of rivals. Indeed, this interpretation is in line with the fact that cycle shifts in 
jealousy have been documented in both single and partnered women (Chapter Two; 
Geary et al., 2001).  
 
To date, all studies investigating menstrual cycle effects on jealousy have been 
conducted within what appears to be largely white undergraduate student 
populations from the Western world. In fact, only a small minority of studies 
investigating the potential for cyclical changes in any preference or mating 
behaviour, has been conducted within a non-white or non-Western population (e.g., 
Flinn, 1988; Penton-Voak, 1999). In a compelling Nature paper Heinrich and 
colleagues (2010) have called to attention to the fact that 70% of all papers 
published in psychology come from studies with participants who are largely white 
American students. With this staggering statistic in mind, in the present research I 
examined cyclical shifts in jealousy among a group of women recruited from 
Curaçao. Curaçao is an island in the South Caribbean Sea off the coast of Venezuela 
which is ethnically comprised of an African-Caribbean majority. In Curaçao racial, 
economic and gender stratification is obvious, with considerable unemployment 
found among the Afro-Caribbean population (Abraham-van der Mark, 2003). 
Matrifocal households are the norm and men tend not to share responsibility for 
their children long-term (Ministerie van Binnenlandse Zaken en Koninkrijsrelaties, 
2010). Given this situation one might predict that loss of investment from an 
initially contributing male partner may be particularly costly to a woman in this 
setting. Therefore, I predicted that competition to maintain mates may be stronger in 
Curaçao than other Western populations. I also predicted, in line with previous 
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evidence, that fertile cycle phases would be associated with higher levels of 
jealousy than non-fertile phases.  
 
Replication is essential for the verification and generalization of previous findings 
(Muma, 1993). The replication of results previously found in predominantly white 
Western societies within Curaçao would lend support towards the notion that 
female menstrual cycle shifts, specifically in jealousy, are a universal. Further, the 
mean age of this study sample is substantially older (about ten years) than that 
which is typically used in most previous investigations and a considerably larger 
proportion of the sample consisted of non-students (for comparisons see Chapter 
Two; Gaulin et al., 1997; Geary et al., 2001) which offers further distinctiveness to 




Participants were recruited via word of mouth between November 2010 and 
February 2011 from the capital of Curaçao, Willemstad. A total of 76 women were 
initially recruited, however one participant was excluded from analysis because she 
indicated that she had a reproductive disorder. A second individual was excluded 
because she indicated that she had not been born in Curaçao. A further three women 
reported cycles greater than 40 days, prompting the possibility of pregnancy, and 
were therefore also excluded. As a result of these exclusions the data of 71 women 
were used for analysis. Participants were aged between 18-45 (M = 29.13, SE = 
1.08) and none were using any form of hormonal contraception, pregnant, or 
reported to have been lactating at the time of the survey. All participants reported to 
be of Curaçao descent and half of the sample indicated that they were non-students 
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Fertility scheduling 
Given our cross-sectional design, I employed the crude, albeit commonly used (e.g., 
Havlíček et al., 2005), forward counting method to assign participants conception 
risk. Participants who were recruited on days 9-14 of the cycle were presumed to be 
in a stage of high conception risk, while those outside this window were presumed 
to be in a stage of relatively low conception risk. Based on this classification it was 
determined that 20 participants were in a high conception risk stage, while 51 
participants were in a low conception risk stage at the time of recruitment. While 
our methodology is expedient, and researchers on this topic should aim to improve 
the quality of assigning conception risk (see Chapter Two, Chapter Six and Chapter 
Seven), our study is unique in that it examines menstrual cycle effects within an 
older, non-western, and partially non-student population.  
 
Measurement of dependent variables  
Participants completed a short pen and paper questionnaire containing basic 
demographic measures as well as a 15-item scale for jealousy (Buunk, 1997) used 
in the previous chapter. Participants were asked to respond to items using a one to 
five point scale, with higher scores indicating higher levels of jealousy. Again, 
example items from this scale include: “your partner danced intimately with 
someone of the opposite sex” and “I am afraid that my partner is sexually interested 
in someone else”. In a slight modification from the instructions offered in Chapter 
Two, participants who were single at the time of participation were asked to 
imagine how they would feel in each of the situations based on previous 
relationship experience. Participants could choose to complete the questionnaire in 
Papiamentu or in Dutch, the two official languages of Curaçao. Papiamentu is an 




The mean summed score on the jealousy scale was 54.45 (SD = 11.76) and 47.78 
(SD = 10.84) for fertile and non-fertile participants, respectfully. To examine the 
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effect of fertility status on jealousy response I conducted an independent-samples t-
test (see Figure 5). Results indicated that jealousy was significantly higher among 
the sample of fertile women than among the sample of non-fertile women (t = -2.28, 
p = .026, df = 69, Mean difference = 6.66). When entered into a univariate model 
neither age nor relationship status significantly influenced jealousy scores (all p > 
.31, F < 1.04). Note that when the rates of jealousy among participants in this study 
are compared to the rates of jealousy among the sample of Dutch women used in 
Chapter Two (collapsing across fertile and non-fertile measures), that Curaçao 
women show significantly higher levels of overall jealousy (F = 5.05, p = .026), yet 




















Figure 5. Mean scores (+SE) of participant jealousy scores when fertile and non-
fertile among women from Curaçao 
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Figure 6. Mean scores (+SE) of participant jealousy scores when fertile and non-
fertile among women from both Curaçao and The Netherlands 
Discussion 
 
The present results demonstrate cyclical shifts in the expression of female jealousy, 
with higher levels of jealousy reported when fertile than when non-fertile. With the 
exception of work by Flinn (1988), this study is unique to the literature in that it 
investigates cyclical variation in an Afro-Caribbean population. Further, many 
participants were non-students and the mean age of the sample was older than what 
has been typical in previous research. Previous research has shown that fertile 
periods are associated with increased extra-pair flirtation and mating effort 
(Pillsworth & Hasleton, 2006; Jones et al., 2005). These findings seem at odds with 
the present result: that women show increased fear of in-pair partner fidelity when 
fertile. Assuming that the expression of jealousy carries some cost (e.g., the time 
and energy required to stay vigilant) one could speculate that its expression involves 
a trade-off; otherwise jealousy would function at a maximum ideal level at all times. 
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However, this begs the question of what, if any, advantage women gain from 
increasing jealousy when fertile.  
 
To extend the discussion from Chapter Two, one possible explanation is that shifts 
in jealousy may be the by-product of another adaptive systematic change which 
occurs across the female menstrual cycle. For example, jealousy may shift across 
the cycle as a result of shifting levels of intrasexual competition. Increased 
competitive behaviour when fertile could aid a woman to obtain a mate or 
potentially to secure an individual of higher quality than they typically would, 
thereby enhancing their reproductive fitness. Fisher (2004) has previously shown 
that women derogate female faces more when fertile than when non-fertile. This 
finding suggests that women may be more conscious of rivals when fertile and are 
thus more critical in their assessment of them. The finding that levels of jealousy 
increase when fertile may therefore be the result of the fact that our scale tapped in 
to some form of female-female competition. It may be that increased salience of 
mating competition when fertile influences female jealousy response in some way; 
however at present this remains speculative. This possibility will be addressed in 
Chapter Six, so I will not elaborate further here. You will soon see that intrasexual 
competition does not appear to be an adequate interpretation of the present findings. 
 
A second possibility is that during times of increased conception risk women will 
be particularly salient of continued investment from their male partner. That is, if a 
woman is going to have sex with a man, given the costs associated with rearing an 
infant as a single parent, they may be conscious of the likelihood of continued male 
support. This consideration is most pertinent when conception is possible (i.e., “If I 
am going to have sex with you when I can get pregnant, you really better support 
me”). This explanation is supported by the fact that results suggest that cyclical 
shifts in jealousy occur irrespective of relationship status. In fact, previous results 
described in Chapter Two indicate that cyclical shifts in jealousy were more robust 
among single women than among partnered women.  
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Future research should seek to uncover the specific endocrine mechanism 
underlying these results. Estrogen is an obvious etiological candidate, given the 
pattern of results with respect to hormone shifts across the menstrual cycle and the 
results of Geary and colleagues (2001). However, it remains plausible that the 
pattern is the result of more complex hormonal change, including, for example, the 
relative ratio of estrogen to progesterone. Researchers should also aim to specify the 
target of shifting jealousy: does jealous shift overall or are shifts more specific? In 
our study all items on the jealousy questionnaire asked participants to react to their 
partner (or imagined partner) in a variety of settings. It therefore remains necessary 
to examine shifts in jealousy which are not specific to this target (e.g., to female 
rivals).  
 
Further, while I specifically asked that single women imagine themselves in a 
relationship; again it is not entirely clear how this was interpreted. For example, I 
cannot disentangle if these participants imagined a previous partner, a hypothetical 
partner, or even an ideal partner. It should also be acknowledged that the use of a 
within-subjects design, as in Chapter Two, would have been preferable to the 
between-subjects design utilized herein for convenience in sampling. Future 
research measuring jealousy behaviourally is also warranted to confirm these 
questionnaire based findings.   
 
An important implication arising from our results is that, among women not using 
HC’s, levels of jealousy shift in a predictable fashion across the menstrual cycle. 
Increased jealousy, when fertile, may alter relationship dynamics in partnered 
women. It may be, for example, that temporal shifts in jealousy are associated with 
shifting levels of conflict within partnerships. As it stands, it remains to be 
determined whether or not shifts in jealousy reported are conscious to women 
themselves, or moreover, if they are picked up upon by male partners. Studies 
investigating how shifts across the menstrual cycle influence relationship 
satisfaction for both female and male partners are likely to prove to be an interesting 
avenue for future research.  
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I am grateful to the student volunteers from The University of The Netherlands 
Antilles who collected and organized our survey response data from within the 
Willemstad community. Without the help of these students we could not have 
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Women who use hormonal contraceptives have been shown to report higher 
levels of jealousy than women who are regularly cycling. Here, we extend these 
findings by examining if self-reported levels of jealousy vary with the dose of 
synthetic estrogen and progestin found in combined oral contraceptives in a 
sample of 275 women. A univariate ANOVA analysis revealed that higher 
levels of ethinyl estradiol were associated with significantly higher levels of 
self-reported jealousy. There was, however, no relationship between combined 
oral contraceptive progestin dose and reported jealousy levels. When con- 
trolling for age, relationship status, mood, and combined oral contraceptive 
progestin dose the results for ethinyl estradiol were maintained. A test for the 
interaction between the jealousy sub-scale items (reactive, possessive, and 
anxious jealousy) was however non-significant: ethinyl estradiol dose thus does 
not affect one type of jealousy more than another but rather affects overall 
jealousy. The implications of these findings are discussed in the context of their 
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Relationship jealousy is a central affect that is experienced by both men and women 
(Shackelford et al., 2000; Bringle & Buunk, 1991). Cross-cultural research suggests 
that men are more distressed by sexual infidelity, while women are more distressed 
by emotional infidelity (e.g., Buunk et al., 1996; Geary et al., 1995; Buss et al., 
1992). However, agreement over these findings is not robust (Harris, 2003), and 
both positive (Buss, 2000; Barelds & Dijkstra, 2006) and negative (Shackelford & 
Buss, 2000; Buunk, 1991) associations with jealousy and relationship quality have 
been reported.   
 
Interestingly despite the dispute within the literature to establish or refute the 
existence of sex-specific differences in jealousy, surprisingly little focus has been 
directed towards considering the potential mediating role of individual differences 
in sex hormones on jealousy response. The fact that HC’s are widely used (Groves, 
2009) and come in different doses presents a unique opportunity to study the effects 
of hormones on female jealousy. It is well-documented that women who use HC’s 
do not exhibit the same patterns of behaviour or preferences as regularly-cycling 
women (e.g., Roberts et al., 2008; Miller et al., 2007). I have outlined a great deal of 
this evidence in the preceding Chapters and General Introduction. To date, little 
research has focused on how such HC use might affect patterns of jealousy. In 
Chapter Two, I have provided evidence that among partnered women HC use is 
associated with higher levels of jealousy than when regularly cycling (at least when 
non-fertile). As discussed previously, this finding is in line with Geary and 
colleagues (2001) who showed that the intensity of jealousy response of women 
using HC’s was higher than that of non-users. Relative to women not using the 
HC’s, a larger percentage of women on HC’s also reported that their partner’s 
sexual infidelity would be more upsetting than their partner’s emotional infidelity. 
In a separate study, which examined women who were regularly cycling, Geary and 
colleagues (2001) found that high absolute levels of estrogen in cycle week two 
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predicted higher levels of sexual infidelity. Together these findings suggest a role 
for estrogen in facilitating jealousy response.   
 
In this Chapter I aim to extend these findings by testing if there are differences in 
patterns of jealousy based on the use of different concentrations of combined oral 
contraceptives (COC’s). COC’s are a form of HC which is composed of a 
combination of a synthetic form of ethinyl estradiol (EE) and progestin (South-Paul 
et al., 2008). They are the most common form of HC’s in use. The current medical 
literature classifies COC’s with an EE dose of 20 μg as an ‘ultra-low dose’, while a 
‘low dose’ pill is typically considered to have an EE concentration between 30 μg 
and 35 μg (e.g., Poindexter, 2000; Rosenberg et al., 2000). I used the existing 
medical classification ‘ultra-low’ and ‘low’ dose as categories for comparison 
within this research project. I predicted that affective jealousy response, although 
certainly influenced by a wide variety of factors, may be moderated by individual 
estrogen levels and that the use of HC’s with higher concentrations of EE would be 
associated with higher affective jealousy response.  
 
To examine this possibility as in Chapter Two and Chapter Three, I used Buunk’s 
typology for jealousy. Buunk (1991, 1997) distinguishes between three types of 
jealousy: reactive, possessive, and anxious. While in Chapter Two and Three I 
present the overall results for jealousy, in this chapter given differences across sub-
scales I have chosen to present overall effects in addition to sub-scale findings. 
Reactive jealousy refers to the degree to which an individual experiences negative 
emotions as a result of their partner’s emotional or sexual infidelity. Possessive 
jealousy refers to the degree of effort an individual invests to prevent their partner 
from coming into contact with opposite-sex individuals. Lastly, anxious jealousy 
refers to cognitively generated experiences of anxiety, worry, and distrust which 
relate to one’s partner’s infidelity. I used Buunk’s typology because, in contrast to 
many of the other dichotomous definitions of jealousy, it places jealousy response 
on a continuum from healthy to unhealthy.   
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Participants in the study were 275 women aged 17-35 (M = 22.56, SD = 2.89) who 
had been using hormonal oral contraceptives for at least three months. Participants 
were recruited by word of mouth and from a large European university. Those from 
the university took part in exchange for course credit. All research was conducted 
via an online website set up using Qualtrics survey software. 
 
Measures 
Participants were first asked to report their age, relationship status, and to complete 
the PANAS-X mood scale (Watson et al., 1994). They then were asked to report the 
brand name of their HC pill, the duration of time they had been using it (in months), 
and to report the precise dose of synthetic hormones in each pill.  
 
Participants then completed the jealousy scale developed by Buunk (1997). Again, 
this scale contains 15-items, 5 for each of the respective sub-types of jealousy 
(overall jealousy scale Cronbach’s alpha = .87; anxious sub-scale Cronbach’s alpha 
= .90; sexual sub-scale Cronbach’s alpha = .70; preventative sub-scale Cronbach’s 
alpha = .79). Participants responded on a one to five point scale.  
 
Statistical analyses  
A mean score for the jealousy scale and each of the sub-scales was computed for 
each of the participants. The relationship between EE dose and jealousy score was 
then assessed by means of an ANOVA. Given that there are no clear medical 
classification for COC progestin dose classification, progestin was analyzed as a 
continuous variable.  
 
Finally, I used a GLM to test the specific between-subject effects of EE 
concentration on the three jealousy domains. In this analysis participant PANAS-X 
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mood scale score was used as a control variable, as was participant age, relationship 





The relative influence of estrogen concentration on mean overall jealousy response 
was examined via an ANOVA. This revealed a significant effect (F = 6.81, p < 
.001) of ultra-low versus low EE concentrations on jealousy response (see Figure 
7). This effect was maintained when controlling for age, relationship status, mood, 
and COC progestin concentration. In contrast to EE, COC progestin dose was not a 
significant predictor of self-reported jealousy (p > .05). 
 
Jealousy sub-scales 
Mean participant scores for jealousy response to each of the three sub-scales were 
then calculated (see Table 1). A GLM controlling for mood score on the PANAS-X, 
participant age (each entered as covariates), and relationship status (entered as a 
fixed factor) was used to investigate the potential role of contraceptive EE dose on 
each of these three types of jealousy. This analysis revealed a significant effect of 
contraceptive EE dose on mean reactive responses (t = 3.35, p = .001) and on mean 
possessive jealousy responses (t = 2.10, p = .012). Scores for anxious jealousy were 
in the predicted direction with respect to increasing EE dose, but were not 
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Table 1. Mean and standard deviation of jealousy response scores by jealousy type 
and dose of EE 
     Ultra-low dose EE     Low dose EE 
Jealousy Item Mean SD Mean SD 
Sexual  3.59 .086 3.91 .044 
Anxious 1.97 .093 2.21 .071 


















Low dose  
 
Figure 7. Difference in raw jealousy scores (+SE) for participants using oral 





11 Again, these means (based on a Dutch sample) are significantly lower than those observed 
in Chapter Three (using a Curaçao sample).  
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Our findings demonstrate that COC EE dose directly influences women’s self-
reported jealousy. This result supports ideas by Geary and colleagues (2001), 
stating that high levels of circulating estrogen play a role in behavioural jealousy 
outcomes. It is also in line with the findings presented in Chapter Two and Chapter 
Three of this thesis, suggesting that estrogen, whether synthetic or natural, 
influences female jealousy response. The other key finding of this study is the lack 
of a relationship between synthetic progesterone dose and reported jealousy. This 
finding is in line with previous research and suggests that estrogen is most 
intimately involved in emotional behavioural outcomes (Fink et al., 1995; Steiner et 
al., 2003). 
 
These findings are important for three reasons. The first is a practical point: when 
considering designs for future research on, for example, female mate choice and 
preferences, it may be important not just to distinguish between HC users and non-
users, but also between those pill-users on ultra-low and low EE concentrations. 
Furthermore, our result draws attention to the effect size of the many studies which 
have been conducted by simply comparing pill and non-pill users without reference 
to EE dose: depending on the proportion of ultra-low versus low dose users within 
such studies, effect sizes may have been under- or overestimated.   
 
Secondly, increased jealousy response could be seen as a negative side-effect of 
estrogen which has received little attention. Although there is an existing push 
towards developing COC’s with lower levels of EE, this is largely due to the 
physical side-effects which result from higher EE concentrations (Poindexter, 
2000). With the exception of studies focusing on female mood changes (e.g., 
Oinonen & Mazmanian, 2002; Joffe et al., 2003) and effects on mate preferences 
(see below), studies which document additional behavioural variables associated 
with COC have lagged behind those investigating physical outcomes. Although this 
study does not speak towards the benefits of HC use, of which there are many, it 
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seems that women, and perhaps pharmaceutical providers, are not fully aware of the 
range of potential behavioural side-effects associated with pill use and more 
specifically brand choice.   
 
Thirdly, this study supplements the existing literature which suggests that HC pill 
use may influence female mate choice preferences and relationship dynamics. For 
example, evidence indicates that, relative to non-pill users, women on COC’s show 
no or weaker preferences for masculine faces and voices (Little et al., 2002; 
Feinberg et al., 2008), and altered preference for genetic dissimilarity in partners 
(Roberts et al., 2008; Havlíček & Roberts, 2009). It may be that pill-associated 
changes in preferences for masculinity and genetic dissimilarity are mediated not 
just by the absence of an estrus phase but also by COC concentrations. Finally, the 
levelling effect that oral contraceptives provide compared with hormonal 
fluctuations across normal cycles may alter important temporal patterns in jealousy 
and responsiveness within pair-bonds. Since I find that women using low-dose COC 
report higher levels of jealousy compared to those using ultra-low doses, it may 
mean that these women suffer to a greater extent in forming and maintaining a pair 
bond.     
 
One might argue that the causation of these findings is difficult to deduce. 
However, despite the potential for self-selecting differences between women using 
low and ultra-low concentrations, women in our sample did not differ in age or 
relationship status. Moreover, there are no clear medical guidelines according to 
which doses of COC’s should be prescribed. However, following Roberts and 
colleagues (2008) and Chapter Two’s methodology for attributing cause to 
behavioural consequences of COC use, future studies that make use of a within-
subjects design (e.g., measuring changes in behaviour as women switch from one 
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Research shows that women who use HC’s differ in their mate preferences 
from women who have regular cycles. It has been proposed that when a 
partnered woman either begins to use or ceases to use HC’s, she may 
experience changes in her relationship since her preferences become 
incongruent with those prevalent at the time of her partner choice. This has 
not yet been directly tested. Here, in doing this, we aim to specifically test 
whether current and past HC use contributes to present levels of relationship 
jealousy. We find a significant interaction in levels of jealousy based on current 
HC use and HC use at the start of the relationship. When current HC use is 
incongruent with that at the start of the relationship, women report 
significantly higher levels of jealousy. Results are the first to suggest that both 
current and past HC use may influence relationship outcomes.
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A number of divergent factors influence female partner preferences at the initiation 
of a romantic relationship. Research from an evolutionary perspective, for example, 
has shown that women experience shifts in mating preferences across the menstrual 
cycle (reviewed in Gangestad & Thornhill, 2008). To reiterate from the General 
Introduction, when fertile as compared to non-fertile, women have been shown to 
prefer increased levels of relative masculinity in faces (Penton-Voak et al., 1999), 
bodies (Little et al., 2007), voices (Feinberg et al., 2006; Puts, 2005), scents 
(Grammer, 1993; Havlíček et al., 2005) and behaviours (Gangestad et al., 2007; 
Gangestad et al., 2004). Likewise, women are known to increase their preference 
for men with bilaterally symmetric traits when fertile (e.g., Gangestad & Thornhill, 
1998; Rikowski & Grammer, 1999; Thornhill et al., 2003). Masculinity and 
symmetry are argued to be costly traits, which are difficult to maintain, and 
therefore are thought to index physical quality (e.g., Schieb et al., 1999). Cyclical 
shifts in female mating psychology may therefore function, in part, to aid women in 
choosing a partner of high physical quality when conception risk is highest 
(Gangestad & Thornhill, 2008; Little & Jones, 2012).  
In contemporary populations however, the use of HC’s among young women 
desiring reliable and reversible contraception is widespread. At present, more than 
100 million women worldwide are currently using “the pill” for contraceptive 
purposes (Trussell, 2007). Recent evidence suggests that use of HC’s interferes with 
the aforementioned cyclical shifts in female mating preferences (reviewed in 
Alvergne & Lummaa, 2010). This is because HC’s suppress female fertility and 
flatten hormonal shifts which occur across the cycle (Frye, 2006). This may suggest 
that women who use HC’s may be less attuned to indicators of male physical 
quality than women who have regular cycles and therefore that they may 
subsequently actually choose partners of lower physical quality than they otherwise 
would. This concept is best supported by evidence obtained from studies examining 
preferences for genetic dissimilarity at the Major Histocompatibility Complex 
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(MHC). The MHC codes for proteins involved in immune self/non-self-recognition, 
and increasing consensus for a link between overall MHC-heterozygosity and 
fitness has been established across a range of species including humans (e.g., Penn 
& Potts, 1999; Penn et al., 2002; Roberts et al., 2005). MHC-dissimilarity may be 
assessed via odour, and regularly cycling women appear to prefer the scent of 
MHC-dissimilar men, and relatively more often find that these odours remind them 
of their actual or former real-life partners (Wedekind et al., 1995). However, on 
initiation of HC’s, women show a shift in preference towards the scent of men who 
are MHC-similar, suggesting that such use may interfere with adaptive mate choice 
(Roberts et al., 2008).   
Little and colleagues (2013) have recently provided additional support for the idea 
that HC use interferes with natural female mating preferences. First, in a laboratory 
based study, they tracked women’s facial masculinity preferences prospectively as 
they initiated use of HC’s. They showed that preferences for masculinity in 
opposite-sex, but not same-sex, faces decreased following initiation of HC’s. These 
shifts were not observed in a control group. Further, using real-world couples, they 
showed that women who met their partner while using HC’s were more likely to be 
paired with men who were rated lower in overall facial masculinity than those who 
met their partner when they had regular cycles. This finding is in line with other 
research which has shown that women who use HC’s show no shift, or a very weak 
shift, in preferences for increased masculinity across the cycle (Feinberg et al., 
2008; Little et al., 2002). Somewhat less intuitively related to these findings, is the 
result of Jones and colleagues (2005) showing that women display a greater relative 
preference for health in the non-fertile phase of the menstrual cycle, and similarly, 
that HC users have higher overall preferences for health in faces than non-HC users. 
Taken together this suggests that masculinity and perceived health are judged 
distinctly from one another since preferences shift in opposite directions across the 
cycle and during HC use (e.g., Little et al., 2002; Little et al., 2008). Finally, in 
contrast to women with regular cycles, women using HC’s also do not exhibit a 
mid-cycle peaks in attractiveness (e.g., Kuukasjarvi, et al., 2004; Miller et al., 2007) 
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or changes in symmetry preferences (Gangestad & Thornhill, 1998; Thornhill & 
Gangestad, 1999). 
In the current study, I sought to expand on previous research which has examined 
HC pill effects on mate preferences through investigating if there are consequences 
of HC use for romantic jealousy. Jealousy is a basic affect which is aroused in 
situations where there is a loss, or a perception of loss, of a valuable relationship 
(Buunk, 1991). Jealousy can be seen as adaptive in that it may help to allow an 
individual to control and monopolize reproductive access and investment from their 
partner. I examined two possible ways in which contraceptive use might influence 
jealousy. First, in a replication of previous work (Geary et al., 2001; Chapter Two, 
Chapter Three) I tested the possibility that current contraceptive use increases levels 
of jealousy. Secondly, I tested the possibility that jealousy is mostly influenced by 
the congruency between current HC use status and that at the start of the 
relationship. This is a novel angle to approach the effects of HC’s. More 
specifically, I propose that, because women who use HC’s do not exhibit cyclical 
shifts in the preference for indicators of physical quality, a partnered woman who 
transitions either on to or off of HC’s, may no longer be satisfied with her partner to 
the same extent. That is, the traits a woman chose in her partner at the start of the 
relationship may no longer satisfy her preferences when she changes her HC use 
status. For example, a woman who chooses a partner off of the pill may choose an 
individual who has outward indicators of physical quality such as a masculine facial 
structure; however, upon her transition to HC use she may find that her general 
preference shifts towards more feminine faces, and as a result, is no longer satisfied 
to the same degree by her partner. Herein, I will refer to this idea as the concept of 
contraceptive (in)congruency. I predict that such disruption in preferences may 
leave women with feelings of uncertainty about their relationship which may 
prompt feelings of jealousy. Indeed, previous research has shown that jealousy is 
provoked in situations of relationship uncertainty, and that jealousy is positively 
related to feelings of anxiety about one’s attachment to their partner (e.g., Afifi & 
Reichert, 1996; Dainton & Aylor, 2001; Knobloch, 2005).  
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There is some recent evidence that contraceptive congruency, the correspondence 
between current HC use status and that at the initiation of a romantic relationship, 
may influence relationship dynamics. Roberts and colleagues (2012) showed that 
HC use versus non-use at the time of meeting one’s partner plays an important role 
in future relationship satisfaction, both emotionally and sexually. They showed that 
women who met their partners when using the pill reported greater emotional 
satisfaction within their relationship, but lower levels of sexual satisfaction than 
women who had met their partner off the pill. This represents an unrecognized 
consequence of HC use that, until recently, had not been considered. Moreover, this 
study was the first to show that these subtle shifts have consequences for the quality 
of actual romantic relationships meaning that HC use could have long-term 
downstream consequences for relationships. Based on this finding, if contraceptive 
use changes or becomes incongruent to the start of the relationship, it may be that 
the dynamics of the relationship, and therefore potentially the expression of 
jealousy, are altered.  
To summarize, I predicted that (1) current HC users will report higher levels of 
jealousy than women not currently using HC’s, and that (2) incongruency between 
current HC use and contraceptive use at the time of meeting one’s partner will 




 Participants completed an online questionnaire which contained basic demographic 
items and the 15-item scale to assess jealousy (Buunk, 1997). Responses to the 
jealousy scale items were recorded on a 1-9 point scale, with higher scores 
indicating higher levels of jealousy (Cronbach’s alpha = .86). Scores on the jealousy 
items were summed to obtain an overall measure on the scale. Participants also 
indicated how long they had been in their current relationship on a five-point scale 
(0 to 6 months, 6 to 12 months, 12 to 18 months, 18 to 24 months, and >24 months), 
if they were currently using HC’s and whether at the time they started their 
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relationship with their partner they were using HC’s or not (or if they “could not 
remember”). Responses to these last questions served as our key independent 
variables. Participants were also asked to report on general satisfaction within their 
relationship. This was captured by a single item question which asked “Overall, 
how satisfied are you in your relationship”, answers being recorded on a 0-100 
point scale with higher scores indicating greater levels of satisfaction. 
 
Participants 
Participants were 129 female undergraduate students from a large European 
University who received course credit for their participation. Participants completed 
all survey measures in their native language. All participants indicated that they 
were presently in a romantic relationship at the time of survey. They were told that 
we were conducting a study on relationship satisfaction. We excluded eight 
individuals from the analyses because they indicated that they were not exclusively 
heterosexual. This exclusion was made due, in part, to the fact that some jealousy 
scale items specifically asked for participants to imagine one’s partner interacting 
with an opposite sex individual. No participant indicated that they did not remember 
whether they were using HC’s at the time they started their relationship. A final 
sample of 121 participants was used for analysis, of which current HC use status 
was congruent with that when they started their relationship for 87 women. Among 
these ‘congruent users’ 71 were using HC’s and 16 had regular cycles. The 
remaining 34 participants were ‘incongruent users’, and the vast majority had 
switch on to as opposed to off of HC since starting their relationship (N = 30). 
Participants reported to be born between 1961 and 1995 (N = 111 due to missing 
cases, M = 1990.59 (~22 years), SD = 3.65) and had dated their current partner on 
average for approximately one year (5 categories; 1 = 0-6 months, 2 = 6-12 months, 
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We first conducted a univariate ANOVA with jealousy as the dependent variable 
and current contraceptive use a as a fixed-factor (without considering congruency 
effects). This revealed a significant effect of contraceptive use (F = 3.94, p = .049), 
with women currently using HC’s reporting higher levels of jealousy than those not 
currently using HC’s (mean difference ± SE = 9.11±4.59), a finding which is 
consistent with previous research (e.g., Chapter Two; Geary et al., 2001). 
We then conducted a univariate ANOVA with jealousy as the dependent variable 
and initial contraceptive use at the start of the relationship and current contraceptive 
use status as fixed factors. The results of this analysis revealed a significant 
interaction between contraceptive use status when starting the relationship and 
present contraceptive use status (F = 3.94, p = .050) (Figure 8). In this instance 
current HC use (F = .89, p = .35) as well as HC use at the start of the relationship (F 
= .98, p = .32) did not have a significant influence on the model.   
Adding age to the model also did not influence the significance of the interaction (F 
= 4.04, p = .047) and age did not have a significant influence overall (F = .001, p = 
.98). Note that data for age from 11 individuals was missing for this analysis. The 
same pattern of results was found when relationship satisfaction was added to the 
model: the interaction remained significant (F = 4.89, p = .029) but relationship 
satisfaction was non-significant (F = 2.18, p = .14). Adding relationship length to 
the model as fixed factor (mean split) influenced the overall effect of the interaction 
such that it became marginally significant (F = 3.48, p = .065); however, 
relationship length did not have a statistically significant effect on the model (F = 
1.68, p = .20) and again current use (F = 1.14, p = .29) and use at the start of the 
relationship (F = .64, p = .42) were non-significant in this model.    
Based on these results we conducted a univariate analysis with jealousy as the 
dependent variable and present HC congruency with that at the time of initiating the 
relationship (congruent versus incongruent) as a fixed factor to test our congruency 
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hypothesis. Results from this analysis indicated that women whose contraceptive 
use status was incongruent with when they met their partner were significantly more 
jealous than those women whose status was congruent (mean difference ± SE = 7.55 
± 3.79, F = 3.96, p = .049) (Figure 9). As previously, we then controlled for 
participant age and relationship satisfaction by separately adding these items to the 
model as covariates. Neither of these variables had a statistically significant effect 
on the model (all F < 1.93, all p > .17) and in all cases the congruency factor 
remained significant. We also added relationship length to the model as a fixed 
factor, but it did not have a significant effect on the model (F = 1.90, p = .17) and 



















When you started your relationship 
were you using HC?  
Figure 8. Test for the interaction of current and former HC use on levels of 
romantic jealousy (+SE).12 
                                                            
12 A vigilant reader will notice that the mean scores on these scales are substantially higher 
than those previously obtained. Note that this is due to the fact that jealousy scores were 
recorded on a one-to-five-point scale in Chapters Two through Four, while the present data 
was recorded on a one-to-nine-point scale. 
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Figure 9. Mean jealousy scores (+SE) as a function of contraceptive congruency 




Our results indicate that the congruency between current HC use and HC use at the 
start of a relationship has consequences for the expression of romantic jealousy 
within that partnership. Specifically, we find that, when controlling for a variety of 
potentially relevant factors, women report higher levels of jealousy if their HC use 
status is incongruent (as opposed to congruent) from when they initiated their 
relationship. This finding complements existing literature which suggests that use of 
HC’s, which suppress cyclical variation in hormones, may interfere with adaptive 
preferences for indicators of physical quality which occur among regularly cycling 
women (e.g., Puts, 2005; Havlíček et al., 2005; Gangestad et al., 2004). 
Accordingly, switching use of HC’s within an existing relationship may shift female 
preferences, and this may change the way that women perceive their partners. This 
suggests that transitioning from non-use to use of HC’s can be disruptive for a 
relationship, but that so long as a woman uses HC’s throughout the whole 
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relationship, while her preferences differ from when regularly cycling, her 
preferences are stable. Newfound uncertainty in one’s partner, or one’s shifted view 
on how their partner satisfies them when switching use status, may explain the 
feelings of jealousy documented herein (e.g., Afifi & Reichert, 1996; Dainton & 
Aylor, 2001; Knobloch et al., 2005). 
Our data also showed that when not considering effects of use at the start of the 
relationship, at baseline, jealousy levels were significantly higher among women 
who currently use HC’s than those who have regular cycles. This result is consistent 
with previous research (Chapter Two; Geary et al., 2001). However, it should be 
acknowledged that an even better test of this effect would have considered 
menstrual cycle stage of the regularly cycling women since it is known that jealousy 
levels increase during the fertile phase (Chapter Two; Geary et al., 2001).  
Future research should seek to test an additional possible influence of HC pill 
effects, namely differences in behaviour based on ever having used HC’s versus 
never having used HC’s. It may be that there is a selection bias in the types of 
women who choose, at any point in their life, to use HC’s. Such differences may be 
driven, for example, by religiosity or personality characteristics. However, in The 
Netherlands, where the current study was conducted, such a strong selection bias is 
unlikely. The Dutch have a very open discussion on sexuality within the mass 
media, with sex education beginning at a young age, and educational campaigns on 
contraceptive use which target hard to reach groups. Moreover, previous research 
exists which suggests the HC pills containing higher doses of synthetic estrogen are 
associated with higher levels of jealousy and mate guarding behaviour (Chapter 
Three; Welling et al., 2012). Unfortunately, information with respect to HC brand 
was unavailable in the present sample. This however, presents an interesting further 
possibility which can be examined in future studies, namely, how one’s relative 
degree of HC congruency effects romantic jealousy. That is, women who met their 
partner on one form of HC and then subsequently switched to an alternative brand, 
can be considered to be ‘more congruent’ than those who changed HC use status 
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altogether. Future research recruiting larger samples with information on current 
and past brand type should aim to investigate this possibility.   
A limitation to this research is that it did not consider how feelings of jealousy 
might translate into or prompt actual behavioural change. The extent to which 
differences in jealousy influence differences in behavioural outcomes between 
women whose contraceptive use status is congruent versus incongruent to when 
they met their partner therefore remains to be determined. However, it is 
worthwhile to note that the systematic study of jealousy may be difficult in that its 
expression can take many forms, and more importantly, it is often only displayed 
privately. Indeed, feelings of shame are often reported for expressing jealousy, 
therefore individuals may attempt to conceal or disguise such feelings (Clanton & 
Smith, 1977). Based on this, the differences in self-reported upset reported on the 
jealousy scale we used are therefore likely to reflect observable differences. 
Moreover, the finding of Welling and colleagues (2012) which showed that women 
on HC’s, particularly those higher in synthetic estrogen dose, display heightened 
levels of mate guarding suggests that behavioural changes are occurring.  
Finally, on average our participants had only been dating their partner for slightly 
more than a year and relatively new relationships may differ tremendously from 
longer ones. Expression of jealousy in a new relationship may alienate the partner 
(Bringle & Buunk, 1985) and jealousy may become more likely after passing 
through the initial passionate stage of the relationship. Nevertheless, the difference 
in jealousy levels depending on congruency of HC use was evident even in this 
sample of relatively young relationships and remained so after controlling for 
relationship length. This difference is consistent with, and is therefore likely to be a 
precursor to, differences in relationship satisfaction experienced among older 
women as a consequence of pill use during initial partner choice (Roberts et al., 
2012). Furthermore, future work recruiting larger samples of women, particularly 
those who transition off of the pill, is necessary to confirm these results since our 
interaction was driven by women transitioning on to the pill. This might be 
accomplished by recruiting samples of older women who may no longer be using 
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HC’s, perhaps because their partner has had a vasectomy, but who still have regular 
cycles. While it is clear that jealousy is higher among women using HC’s, we have 
presented preliminary evidence to suggest congruency matters too. The theoretical 
concepts presented in this paper might also serve to prompt researchers to examine 
other social and relationship factors which contraceptive congruency may influence. 
In summary, our results suggest that changes in HC use over the course of a 
relationship may have a robust influence. Given the potential important social 
implications of increased jealousy within romantic relationships, improving our 
understanding of the mechanism that mediates changes during the transition to or 
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The purpose of this study was to test the influence of HC use on levels of female 
intrasexual competition. Twenty-eight women completed a scale for 
intrasexual competition on three occasions: when using hormonal 
contraceptives and when regularly cycling at a fertile and a non-fertile cycle 
stage. When using HC, pair-bonded, but not single women, reported 
significantly lower levels of intrasexual competition than when regularly 
cycling at either fertile or non-fertile cycle stages. This effect remained 
significant when controlling for age, length of relationship and relationship 
satisfaction. Neither pair-bonded nor single women reported shifts in 
intrasexual competition across the menstrual cycle when fertile as compared to 
non-fertile. This study benefited from a within-subjects design and a more 
rigorous assessment of fertility status (transvaginal ultrasonography) than 
which is typical in the field. Results are discussed in consideration of the 
evolutionary literature on the stability of romantic relationships and fitness 
advantages associated with intrasexual competition. 
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Over 50 years have elapsed since the introduction of HC’s. During this time a great 
deal of research targeting the study of physical risks associated with their use has 
been generated (e.g., Kiley & Hammond, 2007). A new but growing body of 
literature suggests that in addition to physical effects, HC use may also have various 
psychological effects. In particular, the use of HC’s may alter female preferences 
for indicators of male genetic quality and compatibility (Alvergne & Lummaa, 
2010; Roberts et al., 2008). For example, a study by Gangestad and Thornhill 
(1998) found that pill users do not show preference for the scent of symmetrical 
men (an indicator believed to be associated with genetic quality), nor changes in 
symmetry preference across the month when fertile. Moreover, studies investigating 
attractiveness ratings show that there is no variation in such ratings across the cycle 
in men rating contraceptive users or in contraceptive users own preferences across 
the cycle (e.g., Kuukasjärvi et al., 2004; Pipitone & Gallup, 2008; Miller et al., 
2007; Penton-Voak et al., 1999). Such alterations may potentially have evolutionary 
repercussions on relationship formation, long-term relationship satisfaction, and 
potentially upon actual reproductive outcomes.   
 
In the present research, using a within-subjects design, we tested the influence of 
HC use on levels of female intrasexual competition. While studies investigating the 
impact of HC’s typically compare between-subjects who are using HC and those 
who do not, using a within-subjects design is critical because women who use HC 
may differ on a number of dimensions (e.g., religiosity, economic status, 
relationship status) from non-users (Manlove et al., 2007; Kusunoki & Upchurch, 
2011; Guendelman et al., 2000). Intrasexual competition refers to competition 
between members of one sex for access to mating opportunities with members of 
the opposite sex (e.g., Darwin, 1871; Andersson, 1994). It can involve direct 
physical competition but often, particularly between women, takes the form of more 
subtle behaviours such as competitor derogation (e.g., Buunk & Fisher, 2009; 
Fisher, 2004). While relative differences in gamete size and the evolution of 
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parental care may influence sex differences in the intensity of competition, with 
men typically competing to a higher extent for partners than women, certain 
situations are associated with a greater likelihood of female intrasexual competition 
(Trivers, 1972). For instance, in environments where men differ in their ability to 
provide resources or differ in physical health, such that there are few ‘good men’, 
intrasexual competition may be adaptive. In addition, competition may be elevated 
in individuals or environments where women need men more for resource 
provisioning or protection. Work by Burbank (1987) has shown that among women 
in polygynous societies living as co-wives competition exists over food, money and 
paternal care. In these instances intrasexual competition can be considered adaptive 
in that it allows a woman to compete more fiercely to successfully attract a partner 
and monopolize resources.   
 
Previous research suggests that intrasexual competition relating to attractiveness 
varies across the menstrual cycle, with higher levels reported when fertile as 
compared to non-fertile. For example, Fisher (2004) showed that women derogate 
female, but not male, faces more when fertile as compared to non-fertile. Similarly, 
work by Durante and colleagues (2008; 2011) has shown that women non-
consciously select consumer products which might enhance their attractiveness 
(e.g., sexy clothing) when fertile as compared to non-fertile. These findings have 
been explained in light of the idea that, when conception is possible, women have a 
greater desire to outdo attractive rivals to attract a high quality mate. In line with 
this idea, research by Vukovic and colleagues (2009) has shown that post-
menopausal women are less derogating of attractive (feminine) female faces than 
pre-menopausal women. Indeed, postmenopausal women have less to gain from 
derogating same-sex rivals since they can no longer conceive. In light of these 
findings, herein we compared levels of intrasexual competition when using HC’s to 
both fertile and non-fertile cycle stages. To do this accurately we used transvaginal 
ultrasonography which measures actual follicular size, to determine fertility. This 
methodology improves upon the crude, yet typically used (e.g., Fisher, 2004; Miller 
et al., 2007) ‘counting method’ which assigns fertility through counting forward or 
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backwards from the onset of menses to roughly gauge fertility status. Transvaginal 
ultrasonography also allows for the detection of anovulatory cycles in which LH 
surges occur but ovulation fails to follow.  
 
It was predicted that women would report lower levels of intrasexual competition 
when using HC’s as compared to when regularly cycling. Low levels of intrasexual 
competition may be detrimental to female fitness since it may mean that women are 
less likely to achieve or maintain high quality partners and investment. Our 
prediction that intrasexual competition will be lower during HC use is primarily 
based on the idea that HC’s suppress the production of natural hormones including 
testosterone (Bancroft et al., 1991; Alexander et al., 1990; Swinkels et al., 1988). 
There is a large and diverse literature relating testosterone to competitive behaviour. 
For example, in female sporting competition testosterone is known to increase in 
anticipation of competition and is negatively related to losing (Bateup et al., 2002). 
Women have also been shown to release adrenal steroid hormones such as 
testosterone to facilitate courtship behaviour with high quality males. Preliminary 
evidence also suggests that HC use may disrupt this natural inclination to compete 
to obtain a mate: women using HC’s did not experience increases in testosterone 
when in the presence of an attractive man (Lopez et al., 2009). Research by a 
number of investigators has also shown that higher dominance scores are associated 
with higher serum testosterone levels (e.g., Grant & France, 2001; Mazur & Booth, 
1998; Mehta et al., 2009; Mehta & Josephs, 2010). Certainly, testosterone has been 
shown to be positively related to dominance behaviour across a wide range of 
species (e.g., Anestis, 2006; Beehner et al., 2005; Gould & Ziegler, 2007). Some 
evidence suggests that dominance rank in non-human primates is related to actual 
reproductive success, which clearly indicates the adaptive value of competing to 
achieve high rank (e.g., Dunbar & Dunbar, 1977; Noordwijk & van Schaik, 1999; 
Pusey et al., 1997).   
 
If dominance is involved in the expression of intrasexual competition, then one 
would expect women using HC’s to have lower levels of intrasexual competition. 
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There is indeed evidence for a relationship between self-reported dominance (as 
measured by IPIP http://ipip.ori.org/ipip/) and intrasexual competition (as measured 
by Buunk & Fisher, 2009) among women (unpublished data bivariate correlation: r 
= .30, p < .0001, N = 330 women).  
 
In contrast to our idea that testosterone suppression might modify female-female 
competitive behaviour, other researchers have speculated that increases in estrogen 
mid-cycle underlie differences in competitive behaviour across the cycle. While this 
may be valid, it is also plausible that testosterone or a number of different 
hormones, or interactions of combinations of hormones, underlie these changes. To 
our knowledge no research has actually empirically shown that individual 
differences in measured estrogen reliably predict differences in intrasexual 
competition. Similarly, we know of no study showing that differences in the 
magnitude of estrogen change prior to ovulation (either between women or between 
months within an individual) actually relates to intrasexual competition. The 
concept that estrogen governs shifts across the menstrual cycle is however in line 
with research which has shown that individual differences in estrogen predict 
preferences for physical features such as masculinity assumed to be indicative of 
good genes (e.g., Feinberg et al., 2006; Roney & Simmons, 2008) and similarly that 
within-women shifts in estrogen predict attraction to cues of men’s testosterone 
(Roney et al., 2011).  
 
If intrasexual competition is governed by testosterone as we assume, we might 
expect to see higher levels among women when fertile as opposed to non-fertile 
since testosterone has been shown to fluctuate cyclically increasing from 
menstruation to mid-cycle in proximity to ovulation (Alexander et al., 1990; Bloch 
et al., 1988; Morris et al., 1987; Persky et al., 1978; Welling et al., 2007; Judd & 
Yen, 1973). However, other research suggests that changes in testosterone across 
the cycle, while significant, can be ignored since daily fluctuations (due to circadian 
rhythm) and seasonal fluctuations are greater (e.g., Dabbs and de La Rue, 1991). 
Some research even indicates that testosterone levels are stable across the menstrual 
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cycle (e.g., Pearlman et al., 1967; Dabbs, 1990; Schultheiss et al., 2003; van 
Goozen et al., 1997; Leining et al., 2010). If this is true, and if testosterone shifts 
underlie the effects, we would not necessarily expect a difference in intrasexual 
competition scores between the fertile and non-fertile phases of the cycle. 
Furthermore, since we use a scale to measure general intrasexual competition and 
not competition specific to attractiveness, while overall level differences may 
matter, it is unlikely that shifts in general intrasexual competition across the 





Participants were recruited from a pre-existing pharmaceutical trial. Details of 
participant exclusion criteria and recruitment procedures to the trial are consistent 
with those described in Chapter Two. Participants were 28 women aged between 20 
and 31 years (M = 22.90 years, SD = 2.49). Fourteen women reported to be in a 
relationship and fourteen reported to be single. Participants were paid for their 
participation in the study.  
 
Measures 
Participants completed Buunk and Fisher’s (2009) 12-item scale for intrasexual 
competition three times: when using HC’s, when fertile, and when non-fertile. 
Using a 1-7 point scale, participants reported how applicable each of the scale items 
was to them (with endpoints labelled ‘not at all applicable to me’ to ‘completely 
applicable to me’). Examples of scale items include, “I want to be just a little better 
than other women.” and “I tend to look for negative characteristics in women who 
are very successful”. The scale had high reliability across items at each time 
measure (Cronbach’s alphas between .8-.9). Pair-bonded participants were also 
asked at each survey measure to report how satisfied they were in their relationship. 
Scores were obtained from a single-item question, on a scale ranging from 0 to 100, 
with endpoints “not at all” and “completely”, respectfully.  
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Procedure 
At the time of recruitment participants had been using a combined oral 
contraceptive (which was prescribed by their family doctor) for at least three 
months. Immediately following recruitment participants completed their ‘hormonal 
contraceptive use’ survey on an active pill day. Participants then ceased use of their 
HC and underwent a washout cycle in which no measurements were taken. 
Following subsequent menses, on day nine of the cycle we began to track 
participants approximately every 3 days via transvaginal ultrasonography (GE 
Voluson E8 device, with a 4-8 MHz vaginal transducer) to observe follicular 
growth and access fertility. Participants were instructed to complete their ‘fertile’ 
survey as soon as possible when a dominant follicle, which was greater than or 
equal to 13 mm in size, had developed and the fertile phase of the cycle had been 
entered. Based on this criteria participants in our sample completed the fertile 
survey around day 14 (M = 14.70, SD = 3.42). We continued to observe participants 
via transvaginal ultrasonography to ensure that ovulation took place. Participants 
were scheduled to complete their ‘non-fertile’ survey approximately 6 days after we 
had observed ovulation but before the onset of anticipated menses (M = 11.29 days 
after fertile survey, SD = 3.43). 
 
Predictions were tested using hierarchical linear mixed models, with measurements 
nested for each subject and a random intercept at the participant level (SPSS, 15.0). 
Parameters were estimated by Restricted Maximum Likelihood and the model had 
absolute convergence in terms of loglikelihood, parameter and Hessian 
convergence. In the initial model scores on the scale for intrasexual competition 
were entered as the dependent variable, with fertility status (pill use, fertile, non-
fertile) and relationship status as fixed factors. Subsequently, we analysed the data 
for single and pair-bonded women individually adding age, length of relationship 
and relationship satisfaction as covariates. Note that when analysed using repeated 
measures ANOVA’s results were consistent to those reported herein. 
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The overall effect of fertility status on intrasexual competition obtained from the 
linear mixed model was non-significant (F = 2.08, p = .14) as was the main effect 
for relationship status (F = .004, p = .95). However, the interaction between 
relationship status and fertility status within this model was statistically significant 
(F = 3.27 p = .046). Given this interaction, we proceeded to re-analyse the data for 
single and pair-bonded women separately. For pair-bonded women, the overall 
linear mixed model was significant (F = 5.68, p = .009). Pairwise comparisons 
indicated that levels of intrasexual competition were significantly lower during HC 
use than when regularly cycling at fertile as well as non-fertile phases (HC vs. 
fertile: Mean difference = -5.21, SE = 1.64, p = .004; HC vs. non-fertile: Mean 
difference = -4.14, SE = 1.64, p = .018). When regularly cycling, there was no 
significant difference between levels of intrasexual competition at the fertile as 
compared to the non-fertile stage (Mean difference = 1.07, SE = 1.64, p = .52) (see 
Figure 10). Participant age (F = 1.31, p = .275), length of relationship (F = .21, p = 
.65) and relationship satisfaction (F = .58, p = .45) did not have significant effects 
on the model. For single women, the overall linear mixed model was not significant 
(F = .485, p = .62). Among single women, there was no significant difference in 
levels of intrasexual competition when using HC’s or when regularly cycling (Mean 
difference = 1.21, SE = 1.92, p = .53; Mean difference = -.64, SE = 1.92, p = .74), 
nor was there a significant shift in levels across the menstrual cycle when fertile as 
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Figure 10. Levels of intrasexual competition (+SE) when using HC’s as compared 
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Figure 11. Levels of intrasexual competition (+SE) when using HC’s and when 
regularly cycling among single women. 
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We predicted that HC use, which lowers testosterone levels (e.g., Bancroft et al., 
1991; Alexander et al., 1990; Swinkels et al., 1988), would be associated with lower 
levels of intrasexual competition than when regularly cycling. Our results supported 
this prediction but only among pair-bonded women. This may be a result of the fact 
that intrasexual competition functions differently in single versus pair-bonded 
women. Single women, who have not already obtained a mate, may be less 
influenced by decreases in steroid hormones such as testosterone during HC use 
because, overall, the cost of not competing for a mate is higher. It is, for example, 
possible that single women’s generalized desire to obtain a mate overrides potential 
effects of contraceptive use.   
 
Our results also showed that, when regularly cycling, for both single and pair-
bonded women, there was no significant difference in levels of intrasexual 
competition when fertile as compared to non-fertile. Previous research has shown 
that women more strongly degrade the attractiveness of female faces during phases 
of high, relative to low, fertility (Fisher, 2004). Likewise, Durante and colleagues 
(2008; 2011) showed that women unconsciously aim to look more attractive when 
fertile, placing them in a better position to compete with rivals. If this is taken as 
behavioural evidence of intrasexual competition, at first glance, our findings require 
further explanation. Firstly, it should be acknowledged that Fisher (2004) used a 
between-subjects sample in her study. Failing to track women prospectively across 
the cycle may mean that results are a product of subtle group differences between 
women who were fertile versus non-fertile at the time of survey. Furthermore, 
physical attractiveness is one of a number of dimensions on which women may 
compete intrasexually. Accordingly, because we used a scale to measure intrasexual 
competition which encompasses several broad domains in which competition may 
occur, our results in contrast to those of Fisher (2004) and Durante and colleagues 
(2008; 2011), are not specific to competition in the arena of physical attractiveness.  
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Our results do not provide evidence for the concept that mid-cycle shifts in estrogen 
promote intrasexual competition. Estrogen may be responsible for intrasexual 
competition as it relates to attractiveness; however, since we do not observe a shift 
in intrasexual competition mid-cycle when estrogen is high, it is difficult to 
implicate estrogen levels as the mechanism behind shifts in general competitive 
behaviour. In line with literature examining the role of testosterone in competition, 
and the notion that testosterone is suppressed during HC use, we suggest that 
testosterone is the mechanism behind the lower levels of generalized intrasexual 
competition observed.  
 
If testosterone influences the expression of intrasexual competition, the absence of 
cyclical shift in reported levels of intrasexual competition documented herein can be 
considered consistent with finding that testosterone is stable across the cycle. 
However, given that other scholars report an increase in testosterone mid-cycle, an 
alternative explanation may be that shifts in testosterone across the cycle are smaller 
in magnitude to those which occur upon the transition to HC use. As a result, 
women’s expression of intrasexual competition at a more general level may not be 
sensitive to these subtle changes.  
 
Using a prospective design, Chapter Two has shown that when women use HC’s 
they report higher levels of jealousy than when they are regularly cycling. 
Preliminary evidence from Chapter Four also suggests that specific types of 
contraceptives, namely those containing higher doses of synthetic hormones, are 
associated with even greater levels of jealousy (see also Welling et al., 2012). 
Interestingly, in the current study and the prospective study on jealousy in Chapter 
Two, significant effects were only observed among partnered women. Taken 
together, this suggests that HC’s may have specific and distinct consequences based 
on the relationship status of the user. Future research which tracks women 
longitudinally as they leave relationships or enter relationships may thus be 
valuable in further explaining these findings.  
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The current research is among the first to document HC induced shifts in female 
behaviour. If HC use indeed lowers intrasexual competition among pair-bonded 
women, this would suggest that users who are pair-bonded may suffer negative 
evolutionarily relevant consequences from their use of HC. For example, lower 
levels of intrasexual competition among HC users might also result in a greater 
potential to have one’s mate ‘plucked’ by another woman, given that HC users may 
be less attentive to cues to competition or threats from external females, or simply 
less likely to respond to such cues. If HC use reduces a natural propensity for 
partnered women to compete for mates it may mean that many women in our 
contemporary population (where HC use is widespread) have a reduced ability to 
attract new mates or to maintain their existing partner. Acquiring a new mate when 
in an existing relationship may allow a woman to obtain more resources from a 
partner. In light of our findings, women using HC’s may be at a disadvantage in that 
they are less likely to seek out and switch to a new partner for whom they might 
acquire additional benefits. Overall, this could impact female fitness since women 
who use HC’s may settle and start families with partners who they otherwise would 
not. Furthermore, selection may have favoured a particular level of testosterone in 
women (so as to ensure women can adequately manage the trade-off between 
mating effort and parenting effort) and within our contemporary population the 
novel use of HC’s may then be altering the mean population levels of testosterone. 
This in turn may have evolutionary outcomes at the individual and population level. 
 
Although the current research provides important insights into the potential for HC 
induced behavioural changes to influence components of mate choice, it is not 
without limitation. For example, the order of testing was not randomized, 
introducing the potential for testing effects. Further investigations should also seek 
to actually measure circulating testosterone levels to assess within-person variation 
in the degree of testosterone shifts when using HC versus regularly cycling. This 
research has the potential to demonstrate individual differences in the effects 
reported. Indeed, it is also possible other hormones, namely estrogen and 
progesterone, which vary across the cycle and during contraceptive use, may be the 
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mechanism influencing these behavioural changes and future research which 
incorporates hormonal assays is required to determine what role, if any, they have in 
the expression of intrasexual competition. Given the literature relating dominance 
and testosterone as well as competitive behaviour and testosterone (e.g., Grant & 
France, 2001; Mazur & Booth, 1998; Mehta et al., 2009; Mehta & Josephs, 2010), 
we think it is most likely that shifts in testosterone explain our findings. Likewise, 
estrogen and progesterone fluctuate in pronounced patterns cyclically among 
women not using HC’s and therefore we would have expected to see a cyclical shift 
in intrasexual competition if these hormones were implicated in general female-
female competitive behaviour. In contrast, cyclical shifts in testosterone are less 
robust and have previously been shown to be lesser than daily fluctuations in 
testosterone (e.g., Dabbs & de la Rue, 1991). To conclude, we hope that these 
findings stimulate further investigations which examine the potential for HC use to 















































































Cobey, K.D., Buunk, A.P., Pollet, T.V. Klipping, C., & Roberts, S.C. (revision submitted). 
Men perceive their female partners, and themselves, as more attractive around ovulation. 
Biological Psychology. 
Women are rated most attractive near to ovulation 




The purpose of this study was to test whether men perceive changes in their 
female partner’s attractiveness as a function of her fertility status. We further 
test how male self-perception varies in relation to partner fertility status. We 
find that men rate their female partner as more attractive near to ovulation 
(when fertile) as compared to during the luteal cycle phase or during hormonal 
contraceptive use. Moreover, our results point to a presently unrecognized 
negative consequence of hormonal contraceptive use on male self-perception, 
with men rating themselves lower in attractiveness when their partner is using 
hormonal contraceptives than when she is regularly cycling. This study 
benefits from the use of transvaginal ultrasonography to detect fertility during 
the regular cycle and the use of a within-subjects design (both across the cycle 
and during hormonal contraceptive use). Results will be discussed in terms of 
their impact on within-couple social dynamics.  
Women are rated most attractive near to ovulation 
 




Accumulating evidence from laboratory studies shows that women are perceived as 
more attractive near to ovulation (Haselton & Gildersleeve, 2011). However, 
research assessing the real world implications of cyclical shifts in female 
attractiveness is largely unexplored. Notable exceptions are studies showing that lap 
dancers earned more tip money (Miller et al., 2007) and that men become more 
proprietary over their partners (Gangestad et al., 2002) when fertile. These effects 
may occur because men perceive physical changes associated with fertility as more 
attractive, or alternatively, because women actually behave more attractively. 
Somewhat surprisingly, however, no study has yet examined the role of cyclical 
shifts in female attractiveness within romantic couples. Here, we investigate 
whether changes in men’s perceptions of their female partner’s occur across her 
menstrual cycle. In addition, we investigate whether such attractiveness changes are 
associated with changes in male partner’s self-perception, since being partnered 
with someone rated as closer to one’s ideal preference is associated with higher 
levels of satisfaction, which may subsequently influence self-perception (Campbell 
et al., 2001). Finally, we test how both these measures may be influenced by use of 
hormonal contraceptives (HC’s), because women who use HC’s do not exhibit the 
aforementioned cyclical shifts in attractiveness or preferences (Alvergne & 




We used a within-subjects design in which couples were first tested while using 
HC’s, and then, following discontinuation and a washout cycle, near to ovulation 
and during the luteal phase. Female fertility was assessed using transvaginal 
ultrasonography, beginning on cycle day nine. Participants completed their non-
fertile survey approximately ten days after ovulation occurred. We tested 14 
committed heterosexual couples, aged 25.00 years (21-31, SD = 2.91) and 23.29 
years (20-29, SD = 2.61) for male and female partners, respectively. Inclusion 
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criteria and test procedures are consistent with those of Chapter Two and Chapter 
Six. 
 
At each survey stage, participants were asked to respond to the following variable: 
'Compared to other [women/men] your age, how attractive do you feel you are?’ on 
a 0-100 slider scale with endpoints ‘much less attractive than average’ and ‘much 
more attractive than average’. Female participants also completed the Menstrual 
Distress Questionnaire (MDQ; Moss, 1968). In addition, male participants 
indicated: ‘Compared to other women their age, how attractive is your partner?’ and 
'Overall, how satisfied are you in your relationship' on a 0-100 slider scale, with 
endpoints being ‘much [less/more] attractive than average’ and 'not at all satisfied' 
to 'completely satisfied'. Finally, male participants reported whether they had sex 




Data were analysed using Hierarchical Linear Mixed Modelling with a random 
intercept using restricted maximum likelihood estimation. We first tested whether 
men were sensitive to changes in their partner’s attractiveness, with male ratings of 
female attractiveness as the dependent variable and female fertility status (HC, 
fertile, non-fertile) as a fixed factor. This revealed a significant overall effect of 
fertility status (F = 3.87, p = .034, Figure 12): males rated their partner as more 
attractive when she was fertile than both when non-fertile (mean difference = 3.71, 
SE = 1.57, p = .026) or using HC’s (mean difference = 3.86, SE = 1.57, p = .021). 
This effect remained significant when controlling for male age, relationship length, 
relationship satisfaction and recent sex (all F < .023, all p > .88); neither did adding 
female mood (MDQ scores; 1 participant missing; F = .015, p = .90) or female self-
ratings of attractiveness (F = .027, p = .87). 
 
Next, we tested whether female cycle phase influenced male partners’ self-
perception. We found a significant overall effect (F = 3.51, p = .045) and pairwise 
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comparisons revealed that men rated themselves as significantly more attractive 
only when their partner was fertile compared to when she was using HC (mean 
difference = 7.50, SE = 2.85, p = .014). Finally, we conducted a similar analysis 
using female self-perceived attractiveness as the dependent variable. This model 
was not significant (F = 1.21, p = .32), indicating that women’s self-perception 





















Male ratings of female partner
HC use Fertile Non-fertile  
Figure 12. Male partner perception and self-perception as a function of conception 
risk. Men perceive their partner to be more attractive when she is fertile than when 
she is either non-fertile or using HC’s. Male self-perception is significantly higher 
when the partner is fertile than when using HC’s. Combining fertile and non-fertile 
measures suggests that men perceive themselves as more attractive when their 
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Our data provide the first evidence that men in relationships detect changes in their 
partner’s attractiveness as a function of cycle phase. Furthermore, cycle phase has 
consequences on male self-perception. The findings complement the existing body 
of literature showing that women are rated as more attractive when fertile as 
compared to non-fertile, and extend findings in this area by documenting a 
significant decrease in perceptions of female attractiveness during HC use. 
Although our sample size is modest, our findings are consistent with theoretical 
predictions and our within-subjects experimental design, which incorporates both 
key cycle phases and use of HC, is statistically powerful. 
 
One possible mechanism for shifts in men’s perception may be differences in the 
female partner’s behaviour. Haselton and Gangestad (2006) found that women 
regard themselves as more attractive when fertile. However, Hill and Durante 
(2009) found that women’s self-esteem was reduced around ovulation, and in our 
sample, female self-perception did not differ across measures, suggesting that this 
may not be responsible for the reported effects in male partners.  
 
We suggest a more likely explanation is a change in perception of women’s 
physical attractiveness (Haselton & Gildersleeve, 2011). For example, women’s 
faces appear more attractive at ovulation compared with the luteal phase (Roberts et 
al., 2004), perhaps due to cyclical changes in facial texture and shape (Oberzaucher 
et al., 2012). Similar changes occur in attractiveness of women’s body odour 
(Havlicek et al., 2006; Kuukasjarvi et al., 2004) and voices (Pipitone & Gallup, 
2008).  
 
Finally, interestingly, while men’s assessment of their partner’s attractiveness was 
equivalent in the two non-fertile measures (HC use, luteal phase), their own self-
perception was lowest when their partner used HC’s. HC use appears to demolish 
cyclical changes in other-rated attractiveness but does not induce an attractiveness 
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difference between users and non-users (Kuukasjarvi et al., 2004). This then raises 
the intriguing possibility that men’s heightened self-perception in their partner’s 
ovulatory phase extends into the luteal phase, in a manner not experienced by 
partners of HC users. Thus, in addition to our novel evidence for cycle-related shifts 
in men’s perception of their partner’s attractiveness, and in their own self-
perception, our results hint at a hitherto unrecognized negative consequence of HC 
































Based in part on: 
Cobey, K.D., & Buunk, A.P. (2012). Conducting high quality research on the psychological 
impact of oral contraceptive use. Contraception, 86, 330-331.  
 
Roberts, S.C., Cobey, K.D., Klapilová, K., & Havlíček, J. (in press). Oral contraceptives and 
female sexual desire: An evolutionary approach offers a fresh perspective. Archives of Sexual 
Behaviour.
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This thesis sought to examine psychological behaviour in intimate relationships 
across the menstrual cycle and during HC use. To date, while an increasing number 
of studies have examined menstrual cycle effects on intimate behaviour, similar 
effects have largely been overlooked within the literature on HC use. If 
unrecognized psychological side effects of HC use exist, staggering numbers of 
women worldwide are being subjected to negative outcomes due to HC use without 
their knowledge. Studies which have attempted to study psychological effects 
resulting from HC use largely focus on changes in general mood or libido (e.g., 
Oinonen & Mazmanian, 2002; Sanders et al., 2001). I have discussed at length in 
the General Introduction possible reasons for why psychological side effects of 
HC’s may not have been given the attention they deserve by researchers. 
Ultimately, it is irrelevant what the cause(s) of this may be: the lack of conclusive 
research is inadequate by any account for the millions of women who use HC and 
their medical providers. Moreover, the existing literature examining changes in 
female social behaviour induced by menstrual cycle shifts and HC use is plagued by 
weak methodological approaches wherein women are compared between-subjects 
and reliable measures are not used to confirm the stage of the menstrual cycle.  
 
The present research sought to improve upon these shortcomings by using within-
subjects designs and to expand the theoretical focus of literature in this area. 
Informed from an evolutionary psychology perspective I specifically sought to 
study subtle interpersonal processes that may be affected by shifts in the menstrual 
cycle as well as by HC use. This thesis was subdivided into two parts, which I now 
provide a brief summary of. Following this, I will elaborate on the implications of 
my findings and discuss theoretical issues that my work on this topic has raised. 
Subsequently, I will provide a discussion of the hormonal mechanisms that I 
speculate are involved in cyclical shifts and HC pill effects on female psychology. 
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Part One: Hormonal influences on female jealousy  
 
Chapters Two through Chapter Five of this thesis examined menstrual cycle and HC 
effects on the expression of female jealousy. Chapter Two describes the results of a 
within-subjects experiment in which women’s self-reported jealousy behaviour was 
tracked when participants were fertile, non-fertile and using HC’s. This study can, 
in many respects, be considered the foundation of my thesis research. Results 
indicated that jealousy levels were higher when fertile as compared to non-fertile. 
Among partnered women, HC use was associated with levels of jealousy equivalent 
to the levels when fertile. This suggests that HC use, at least among partnered 
women, alters the expression of romantic jealousy. To my knowledge, this is just 
the third study in this area which has been published using a within-subjects design 
tracking women on and off of HC’s, and the first study to do so which examined 
jealousy. It contributes to the field as a methodological paper and sets a standard at 
which future HC and menstrual cycle phase research should be conducted.  
 
In Chapter Three, I examined shifts in jealousy across the menstrual cycle among 
women from Willemstad, Curaçao. To date, the vast majority of research 
documenting cyclical shifts in female preferences and behaviour across the 
menstrual cycle comes from Western samples of Caucasian students. This, of 
course, is a general weakness of most psychological research (Henrich et al., 2010). 
Chapter Three is thus among the first studies in the field to examine cyclical shifts 
in behaviour among a sample of African Caribbean women. Also unique to this 
study is that the vast majority of the sample was non-students. In contrast to 
Chapter Two, for ease of sampling, the results reported in Chapter Three are based 
on a more crude between-subjects sample. Again, results indicated that women 
reported significantly higher levels of jealousy when fertile as compared to non-
fertile. Results were maintained when controlling for age, relationship status and 
relationship satisfaction. This finding, in combination with the results of Chapter 
Two, suggests that shifts in jealousy across the menstrual cycle are robust when 
examined across cultures and when assessed via different methods. Interestingly
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when one considers the results of Chapter Two and Three in combination we see 
that while shifts in jealousy across the cycle are consistent in both samples, baseline 
levels of jealousy were significantly higher among women from Curaçao. This is 
likely to be explained by cultural differences in family structure (i.e., female headed 
households) uneven sex ratios and higher rates of economic stratification within 
Curaçao (Abraham-van der Mark, 2003; Ministerie van Binnenlandse Zaken en 
Koninkrijksrelaties).  
 
Since HC use influenced jealousy among partnered women in Chapter Two, I next 
designed a study to determine if all HC’s increase jealousy to the same extent. The 
most commonly used form of HC, the combined oral contraceptive pill, consists of 
synthetic estrogen and progesterone. However, a number of pill formulations which 
differ in synthetic estrogen and progesterone concentration are available on the 
market. To examine the possibility that different contraceptives differentially 
influence jealousy response I recruited a large sample of women who were using a 
variety of forms of combined HC pills. In Chapter Four, I report the results of this 
study, where I found that women who used HC’s containing higher doses of 
synthetic estrogen reported higher levels of jealousy than those women who used 
pills containing relatively lower doses of synthetic estrogen. This result was 
maintained when controlling for age, relationship status and synthetic progesterone 
dose. This is the first study to my knowledge which has examined HC effects on 
female social behaviour more acutely. Results from this study suggest that research 
using a ‘pill user’ versus ‘non-pill user’ comparison simplifies a more complex 
process. Since publishing this finding the results have been replicated by an 
American research group with respect to partner mate guarding (Welling et al., 
2012). This suggests a degree of robustness in the result which demands further 
inquiry. It is important to replicate these finding within other domains of behaviour, 
but also through use of within-subjects designs in which the same woman 
transitions from one form of combined oral contraceptive to another. Considered in 
relation to Chapter Two and Chapter Three, these findings seem to implicate 
estrogen in the expression of jealousy. Work by Geary and colleagues (2001) 
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showing a positive correlation between estrogen and jealousy reports further 
substantiates this idea. However, Geary and colleagues (2001) only found that the 
relationship between estrogen and jealousy was significantly related in cycle week 
two. This finding complicates the association to some degree, suggesting future 
research tracking women over multiple months is needed to clarify this relationship.  
 
Chapter Five reported the results of a study that considered how HC use history 
within a relationship might contribute to present levels of jealousy. I found that 
relationship jealousy is higher among couples in which the woman’s current HC use 
status is incongruent with that at the initiation of the relationship as compared to 
couples whose current use was congruent to use at the start of the relationship. This 
suggests that preferences which are prevalent at the initiation of the relationship are 
altered by subsequently transitioning to HC use and that this has outcomes on 
relationship dynamics. This study is novel in that it is among the first to account for 
HC use at the initiation of the relationship. Future research which tracks couples 
longitudinally as they transition on to or off of HC’s would be an obvious follow-up 
to the findings reported in this chapter. Further, the finding that HC use at the 
initiation of the relationship predicts aspects of downstream relationship satisfaction 
may be relevant to contraceptive prescribers.  
 
Part Two: Explaining shifts in jealousy: The role of attractiveness and intrasexual 
competition 
 
In Chapters Six and Chapter Seven I attempted to disentangle the mechanism 
behind shifts in jealousy across the cycle and during HC use which I documented in 
Part One. As outlined in Chapter Two and Chapter Three it is not immediately clear 
why cyclical shifts in jealousy would be adaptive and therefore enhance fitness. One 
possibility is that levels of jealousy when fertile are a reflection of higher levels of 
intrasexual competition at this time. Indeed, increases in competitive behaviour 
when fertile may help a woman to obtain or retain a high quality mate more easily 
than she otherwise would.  
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I examined this possibility in Chapter Six. To do this I tracked levels of intrasexual 
competition among a group of women who were initially using HC’s but 
subsequently ceased use. Participants reported levels of intrasexual competition 
when using HC’s and when regularly cycling during fertile as well as non-fertile 
cycle stages. Results revealed that in partnered, but not in single women, levels of 
intrasexual competition were lower when using hormonal contraception than when 
regularly cycling. In neither single nor partnered women were shifts in intrasexual 
competition observed across the menstrual cycle. Based on the absence of cyclical 
shifts in intrasexual competition, it does not appear that intrasexual competition 
could be driving the aforementioned increases in jealousy when fertile as reported 
in Chapter Two and Chapter Three. The finding that intrasexual competition is 
lower among pill users (who have suppressed testosterone) is however consistent 
with the idea that testosterone influences competitive behaviour (Archer, 2006). 
Future research is needed to validate the explanation that testosterone suppression 
during HC use underlies the observed difference in intrasexual competition.  
 
Chapter Seven examined cyclical shifts in perceptions of attractiveness. It tracked a 
modest sized group of women and their male partners across the menstrual cycle 
and during HC use as in Chapter Two and Chapter Six. If changes in self-perception 
were to occur across the female cycle, this might explain the shifts in jealousy 
observed in Chapter Two and Chapter Three. A series of laboratory based studies 
have shown that females are rated as more attractive when fertile as compared to 
non-fertile, but there is an absence of studies testing the implications of these subtle 
shifts. The results presented in Chapter Seven indicated that men judge their female 
partners as significantly more attractive when she is fertile as compared to when she 
is non-fertile or when she is using HC. Further, male self-perception was shown to 
be significantly more positive when the female partner was regularly cycling than 
when using HC. In spite of this, there was no difference in female self-perceived 
attractiveness across conditions. This study is novel to the literature in that it was 
the first menstrual cycle study which surveyed men across their female partners 
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menstrual cycle. Previous research has made use of female self-reports of male 
behaviour. As with intrasexual competition, the absence of shifts in self-perceived 
attractiveness across the cycle, suggests that this variable does not explain the 
patterns we observe in the expression of jealousy. Thus, while it remains plausible 
that other factors may influence jealousy, we have not found evidence in our studies 
of what shifts in jealousy, if not adaptive, could be a by-product of.  
 
What’s going on? 
 
One possibility is that shifts in jealousy are a by-product of changes in levels of 
sexual desire. Indeed, it is well known that sexual desire increases near to ovulation 
when fertile (e.g., Bullivant et al., 2004). This is in line with my finding that 
jealousy is higher when fertile as compared to non-fertile (Chapter Two; Chapter 
Three). The pattern of association between sexual desire and HC use is less clear. 
However, concern about the impact of HC use on women’s sexual functioning, 
particularly lowered sexual desire (or libido) has been expressed for almost as long 
as HC’s have been available. Despite numerous studies over several decades, 
however, we still do not know the underlying mechanism for any negative effects, 
nor can we predict which women will suffer from them (Sanders et al., 2001). In 
order to implicate jealousy as a by-product of sexual desire it is necessary to 
understand how sexual desire is impacted by HC use. 
 
Research on this topic has consistently produced mixed evidence, of two kinds. 
First, there is mixed evidence across studies: some report negative associations 
between desire and HC use, others find no effect, and still others report positive 
effects (for recent reviews, see Schaffir, 2006; Burows et al., 2012; Davis & Catano, 
2004; Pastor et al., 2013). Second, within their respective samples, the 
aforementioned studies also consistently report considerable individual variation in 
women’s experience: relatively large proportions of women experience either a 
marked increase or decrease in desire, with others unaffected. For example, in a 
prospective study, 17% had higher frequency of sexual thoughts and 39% had lower 
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frequency, following initiation of HC use (Sanders et al., 2001). The picture is 
further obscured by the fact that direct comparisons across studies are made difficult 
due to wide variation in methodologies and HC formulations under test. The results 
contained in Chapter Five of this thesis showing dose dependent HC effects on the 
expression of jealousy suggest that such comparisons may be problematic. 
Researchers typically conclude, on the basis of these mixed effects, that the 
influence of HC use on sexual desire is complex and likely due to multiple 
psychosocial influences. Indeed, the most recent systematic review concluded that 
“we cannot define a single indicator reliably and clearly characterising a cause-
effect relationship. This is mainly due to the simultaneous and intertwined effects of 
a variety of complex biological, psychological, social, and multidimensional 
factors” (Pastor et al., 2013). While this may be an accurate reflection of the current 
state of play, it is clearly unsatisfactory both to women concerned about possible 
consequences for their relationships and to healthcare providers who are unclear 
about what advice to give. Against this background, new perspectives that might 
help to clarify the issue should be seized upon and scrutinized carefully. Here, I will 
first describe a prediction drawing from the interface between psychology and 
evolutionary biology which may clarify the mixed patterns of results with respect to 
the effect of HC’s on sexual desire. Following this, I will discuss how this 
explanation is consistent with my proposition that jealousy is a by-product of levels 
of sexual desire, and thus provides an explanation for the findings contained in 
Chapter Two through to Chapter Five. 
 
I have previously discussed literature demonstrating the potential for HC use to alter 
women’s partner preference (Alvergne & Luumma, 2010). HC use could therefore 
have important consequences on women’s sexual relationships, because it alters 
both women’s attraction to their partner and, potentially, to other men. Recall, for 
example, that women using HC’s show a shift in preference for MHC similar 
women (Wedekind et al., 1995; Roberts et al., 2008). A study of US women in 
established relationships, showed that those partnered with men who shared a 
relatively high number of MHC alleles expressed lower sexual responsivity and 
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satisfaction with their partner compared with women whose partner was relatively 
MHC-dissimilar, and particularly so around ovulation (Garver-Apgar et al., 2006). 
Furthermore, in the same women, within-couple MHC similarity was also 
associated with higher frequency of women’s sexual thoughts about, and actually 
engaging in sexual activity with, other men. This raises a fundamental consideration 
for studies of the relationship between HC use and female sexual desire: a critical 
distinction needs to be made between a woman’s general sexual desire and her 
specific desire for her partner. Previous studies have almost ubiquitously failed to 
make this distinction. These studies typically employ one of a range of standard 
questionnaires to measure desire, but examination of these scales shows that they 
lack sufficient specificity in their respective lists of items. Table 2 shows the higher-
order facets of female sexuality, and the target (general or partner-focused) 
specified in the questionnaire rubric, for six of the most commonly used 
questionnaires in this area of research. While each of the questionnaires contains 
items that quantify general sexual desire, not one contains an item specifically about 
desire for (nor about arousal, lubrication or orgasm during sex with) the woman’s 
main sexual partner. Furthermore, even though several questionnaires contain items 
relating to partner-focused sexual satisfaction, which is likely correlated with desire, 
these items are often subsumed within global sexuality scores or in desire subscales 
which also incorporate general sexual desire (e.g., Wallwiener et al., 2010; Panzer 
et al., 2006). 
 
Studies demonstrating the influence of HC’s on partner choice lead to a further 
novel, simple and testable idea. This is that congruence between current HC use and 
previous use (specifically during relationship formation) should more accurately 
predict a woman’s sexual desire for, and satisfaction with, her partner than current 
HC use in isolation. This concept is in line with the ideas presented in Chapter Five. 
If a woman’s HC use is congruent (i.e., current HC users who were HC users when 
they met their partner, current non-users who were non-users when they met their 
partner), her current preference will more closely match the preference that shaped 
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her partner choice in the first place. The corollary is relatively higher desire for that 
partner than a woman whose use is incongruent. 
 
The hypothesis generates further testable predictions (Figure 13). One is that 
women who meet their partner while using HC will tend to experience decreased 
desire when they subsequently cease use, as their partner preferences realign to their 
baseline state. A recent study tested this prediction in a survey of >2500 women. As 
predicted, among current non-users, those who had used HC when they met their 
partner reported lower attraction to, and lower sexual satisfaction with their partners 
compared with those who had been non-users (Roberts et al., 2012). A second, but 
so far untested prediction is that women who were non-users when they met their 
partner and who subsequently initiate HC use will tend to experience similar 
negative effects on sexual desire, arousal and satisfaction.  
 
Thus, the congruency hypothesis suggests that decreased desire could be 
experienced both by ceasing and initiating HC, critically depending on the 
individual’s HC use when the relationship began. This could help to explain the 
consistently high variation in women’s experience that is characteristic of previous 
studies. In Chapter Five we show that women whose current HC use status is 
congruent to the start of the relationship express lower levels of jealousy than those 
whose status is incongruent. This finding might be explained by that fact that these 
women have lower levels of general sexual desire because they are satisfied by their 
partner. Thus, jealousy is lower at this time because sexual desire is lower. This 
complements the idea that women express greater jealousy when near to ovulation 
since sexual desire is greater at this time. A study examining congruency, jealousy 
and sexual desire in tandem will clarify the validity of my congruency hypothesis. 
As it stands, I think that changes in sexual desire are the most probable explanation 
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Table 2 | Facets of female sexual experience in six of the most frequently used questionnaires in 
Studies testing associations between oral contraception and sexual functioning.  
Facet and target* Questionnaire‡
FSFI MFSQ SDI SEQ PEQ SPEQ 
General       
Desire + + + + + + 
Arousal + + - - + + 
Lubrication + + - + + - 
Orgasm + + - - + + 
Satisfaction§ + + - + + + 
Pain + + - - - + 
Frequency - + - - + + 
Autosexual - - + - + - 
       
Partner-focused       
Desire - - - - - - 
Arousal - - - - - - 
Lubrication - - - - - - 
Orgasm - - - - - - 
Satisfaction§ + + - - + + 
Pain - - - - + - 
Frequency - - - - + - 
*Facets are presented separately for questionnaire items dealing with general sexual functioning 
and those specifically targeted at sex with a woman’s main partner. ‡Questionnaires: FSFI, 
Female Sexual Function Index; MFSQ, McCoy Female Sexuality Questionnaire; SDI, Sexual 
Desire Inventory; SEQ, Side Effects Questionnaire; PEQ, Personal Experiences Questionnaire; 
SPEQ, Short Personal Experiences Questionnaire. §Includes enjoyment. 
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Figure 13. The figure shows how, according to the congruency hypothesis, 
congruency (light grey shading) or non-congruency (dark grey) in OC use between 
different critical periods predicts variation in partner-specific desire. (a) In cross-
sectional studies, OC use during sampling is associated with both higher and lower 
levels of partner focused desire dependent on previous use during relationship 
formation. (b) In prospective studies, an intervention (i.e. initiating or discontinuing 









Gangestad and Thornhill’s (2008) concept of a dual sexuality, which argues that 
female preferences and behaviours diverge in stages of high and low fertility, 
formed the basis of my initial motivation to study HC effects. Shifts in preference 
and behaviour across the menstrual cycle are claimed to enable a woman to pair 
with a higher quality partner when fertile. This, in turn, is said to be adaptive in that 
any resulting offspring are of higher quality than they might otherwise have been. 
However, it must be acknowledged that the evidence for the idea that specific 
preferences which occur when fertile actually represent underlying ‘good genes’ is 
mixed. Folstad and Karter’s (1992) Immunocompetence Hypothesis argues that 
physical features which are mediated by sex hormones (e.g., masculinity) are honest 
cues to the genetic quality of their possessor. For example, it is known that high 
testosterone is associated with facial masculinity (e.g., Penton-Voak & Chen, 2004) 
and that high levels of testosterone are harmful to the immune system (e.g., 
Messingham et al., 2001). Based on this, it is argued that only those men who are 
healthy enough to tolerate the immunosuppressive consequences of testosterone can 
afford to develop exaggerated traits like masculine faces. While some studies 
strongly supports this idea: with men’s facial masculinity, for example, having been 
shown to be related to apparent health (Johnston et al., 2001) as well as medical 
health records (Rhodes et al., 2003), the findings are admittedly less robust when 
considered across a range of species (see for example Getty, 2002).  
 
Further, it seems to me that while Gangastand and Thornhill’s (2008) dual sexuality 
theory may be valid, there are alternative explanations which may account for the 
observed shifts across the menstrual cycle. One possibility worthy of discussion is 
that shifts in preferences associated with hormone changes in the menstrual cycle 
are actually a by-product of between cycle shifts. For example, while it is well 
known that within-person hormone levels vary within the cycle; hormones also vary 
between-cycles. Relatively high levels of hormones from one month to the next 
may index fertility at a more global level. Research shows that, even in our 
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contemporary populations where resources are plentiful, menstrual cycles in which 
estrogen levels are higher are more likely to result in conception (e.g., Baird et al., 
1999). Based on this, coupled with the fact that throughout human evolutionary 
history women may have experienced long phases in which they were non-fertile, a 
between cycle signal of female conception risk might be adaptive to cue women 
towards interest in sexual activity with good gene partners in the infrequent months 
where conception was possible (Roney & Simmons, 2008).  
 
The notion that cyclical shifts in preferences and behaviours may actually be 
incidentally related to fertility due to between cycle changes is supported by 
research which finds that individual differences in female estrogen levels predict the 
degree to which male masculinity is preferred (Roney & Simmons, 2008). If the 
between-cycle theory is valid, then women may experience changes in preferences 
within a cycle in line with Gangestad and Thornhill’s (2008) ovulatory shift 
hypothesis, as a by-product of estrogen and other hormonal changes that function on 
a different level. In light of this, menstrual cycle shifts in behaviour (and then 
subsequently HC pill effects) should be studied over the duration of multiple 
months of the regular cycle to test the variance explained by the two theories. In 
some respects the between-cycle theory can be considered analogous to breeding 
seasons in animals. Admittedly, it would be difficult to disentangle between- and 
within-cycle explanations.  
 
As an additional point of theoretical issue, I think it is important to note here that 
ovulation itself is not the mechanism responsible for changes observed across the 
menstrual cycle. Hormonal shifts surrounding ovulation are the obvious 
mechanism. Regretfully, I did not have the opportunity to complement the research 
presented herein with hormonal assays; however, this is an obvious measure to 
incorporate into future research to complement the existing methods. I will speak 
later in the discussion at length about the specific hormones likely to be involved in 
my findings. For now, I will return to why ovulation is not a mechanism for 
menstrual cycle shifts in behaviour. Discussion of mechanisms with respect to this 
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topic is often muddied with terms like ‘ovulation phase’ or ‘ovulatory preferences’. 
I think that use of such terminology is an example which illustrates a greater and 
more overarching difficulty among specific camps of researchers publishing on this 
topic, that is, the lack basic foundations in female reproductive biology and more 
specifically of endocrine changes occurring at reproductive life events such as the 
menstrual cycle. One way of reaching a consensus with respect to whether or not 
ovulation can be viewed as a mechanism would be to study cycles where hormonal 
fluctuation occurs, but ovulation does not follow. In these anovulatory events, I 
would predict that shifts in behaviour and preferences still occur. This sort of 
investigation would require the use of transvaginal ultrasonography as in Chapter 
Two, Chapter Six and Chapter Seven of this thesis. 
 
Methodological limitations and requirements for future research 
 
In spite of several notable strengths in experimental methodological approach (e.g., 
within-subject designs, transvaginal ultrasonography, male partner data), a number 
of additional improvements in the design should be encouraged in future research. 
An overarching limitation of the research contained within this thesis is that it is 
heavily reliant on self-reports from questionnaire data. While self-reports may serve 
as a good starting point for investigating changes in behaviour across the menstrual 
cycle and during HC use, future research should aim to observe and measure actual 
behaviour. This avoids the possibility that self-report data is subject to social 
desirability and therefore may not satisfactorily represent behaviour. As it stands, it 
is unclear how the results documented herein translate into actual behavioural 
changes in women and how such behaviour might impact actual relationships. With 
this limitation acknowledged, I would argue that real world behaviours with respect 
to the empirical topics examined, namely jealousy, intrasexual competition and 
attractiveness, are most likely to be consistent with the reported results. This is 
because the topics considered are particularly prone to bias: no one wants to admit 
to being a jealous and competitive woman or to have an unattractive partner! It is 
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therefore somewhat even more compelling that we find shifts in self-reported 
behaviour on these topics. 
 
Furthermore, sample sizes among the studies conducted within-subjects were 
modest due to the invasive and costly techniques used. Future research which 
samples larger groups of women may be able to tackle individual differences in 
effects reported herein. Due to high costs, this is only likely to be achieved through 
the establishment of industry collaborations with pharmaceutical companies. In 
particular, larger samples could examine more specific differences in behavioural 
changes in HC users observed among single versus partnered participants (e.g., 
Chapter Two and Chapter Six) or the influence of current use and use at the 
initiation of the relationship (e.g., Chapter Five). Factors not considered in the 
current research, such as length of time since last relationship among single women, 
may help to identify additional individual differences in HC pill effects.  
 
It may also be of interest for researchers to more closely examine differences in 
behaviour among women using different types of HC’s. Chapter Four suggests that 
a study tracking women prospectively as they transition from one form of 
contraception to another is warranted. Such studies should also seek to examine 
individual differences that might suggest particular women are better suited to 
particular pill formulations. Obvious considerations include participant BMI, 
ethnicity, and age since these are all factors which are known to influence hormone 
levels (e.g., Mul et al., 2001; Wu et al., 2001; Rowland et al., 2002). Identification 
of individual differences in the influence of HC’s on female psychology may 
eventually lead to the development of a more specific guideline for prescribing 
HC’s on a case-by-case basis. 
 
Implicating hormones  
 
The results of the studies presented in this thesis cannot conclusively implicate a 
specific hormone or set of hormones as the mechanism behind the reported changes 
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during HC use. Indeed, this is a valid criticism of the vast majority of research 
examining psychological effects of HC use and even more so of the literature of 
cyclical shifts in behaviour. Based on the results observed herein, I suggest that 
shifts in estrogen across the cycle, and estrogen suppression during HC use, may 
moderate changes in emotional reactivity (e.g., jealousy). This is in line with 
research showing that variation in estrogen levels influences neural correlated 
emotional responsiveness (Amin et al., 2006). This finding is also in line with 
previous research and suggests that estrogen is most intimately involved in 
emotional behavioural outcomes (Fink et al., 1995; Steiner et al., 2003). 
 
Based on this assumption I would argue that estrogen changes are likely to explain 
the findings related to jealousy documented in Chapters Two trough to Chapter 
Five. However, a study which assays estrogen throughout the cycle in a large 
sample remains necessary to validate this interpretation. To accomplish this I would 
conduct a prospective study in which women are tracked across multiple cycles 
prior to transitioning to HC use. Daily hormonal assays, from which one could 
measure the rate of shift in estrogen from the early follicular phase to ovulation, 
would allow for an acute assessment of estrogen changes and their subsequent 
outcome on female psychology. Here, I would predict that if estrogen is the 
mechanism behind cyclical changes in emotional reactivity, women who experience 
a greater absolute change in estrogen levels during the follicular phase would report 
greater shifts in behaviour (see Figure 14 and Figure 15). Likewise, if individual 
baseline levels of estrogen do not correlate with levels of estrogen after 
commencing HC’s, such that estrogen is suppressed to a similar level among all 
users, I would predict that participants who have higher baseline levels of estrogen 
would experience greater changes in emotional reactivity during HC use.  
 
The value of tracking participants through multiple cycles is that one could test how 
differences in the absolute change in estrogen, both within and between cycles, 
influences emotional reactivity. That is, in cycles where an individual experiences 
General Discussion 
Page | 138 
 
higher peak levels of estrogen mid-cycle, I would predict greater shifts in emotional 














Figure 14. Hypothetical estrogen patterns across the menstrual cycle of two 
individuals. I would predict that estrogen pattern 2 (empty) would be associated 
with lesser cyclical shifts in behaviour than estrogen pattern 1 (filled). I predict the 
same pattern between-cycles: if the lines represented estrogen levels of one woman 
tracked over two months I would expect cyclical changes to be less pronounced in 

















Figure 15. Hypothetical estrogen patterns across the menstrual cycle of two 
individuals. I would predict that individuals with higher baseline estrogen levels (as 
in estrogen pattern 2; empty) would be associated with more moderate cyclical 
shifts in behaviour (than estrogen pattern 1; filled). 
 
In addition to the prediction that estrogen moderates results relating to emotional 
reactivity or jealousy, I have speculated that testosterone moderates changes in 
competitive behaviour (Chapter Six). A great deal of research has previously 
implicated testosterone in competitive behaviour (e.g., Archer, 2006). It is for this 
reason, in combination with the weak evidence for predictable testosterone shifts 
across the menstrual cycle (as outlined in Chapter Seven; Pearlman et al., 1967; 
Dabbs, 1990; Schultheiss et al., 2003), that I think that testosterone suppression 
during HC use explains our finding that women are less intrasexually competitive 
when using HC than when regularly cycling. The Challenge Hypothesis argues that 
testosterone facilitates a trade-off between mating and parenting effort (Archer, 
2006). High testosterone is associated with mating effort, while low testosterone is 
associated with parenting effort (e.g., Pollet et al., 2011; Fleming et al., 2002; Perini 
et al., 2012; Storey et al., 2011; Gray, 2003; Burham et al., 2003). This concept 
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isconsistent with the pattern of results observed herein. Research that measures 
testosterone levels is, of course, needed to verify this explanation. Such research 
also has the potential to uncover individual differences in intrasexual competition 
based on testosterone levels. Women who display low levels of intrasexual 
competition may be less likely to engage in self-enhancement activities and 
therefore may suffer negative fitness outcomes.   
 
Finally, how do we explain the fact that men report shifts in their perception of their 
partner’s attractiveness, and more significantly, their own attractiveness near to 
ovulation? While some evidence suggests that men might experience shifts in 
testosterone in proximity to a fertile women (e.g., Miller & Maner, 2010) this 
finding was not replicated successfully when considered using a slightly modified 
design (Roney & Simmons, 2012). I think that it is more likely that men are picking 
up on changes in their female partner’s behaviour and reacting accordingly. 
Importantly, changes across the menstrual cycle need not be overt for men to 
perceive and consequently modify their behaviour. These processes may even be to 
a large extent non-conscious. Of course, male hormones may be involved in this 
process but at this stage research in this area is only beginning to discover what 
changes male partners might experience as a result of their partners cycle or HC 
use. Therefore, at present, it appears premature to single out a particular hormone or 
set of hormones which explain our male findings.  
 
Finally, it needs to be acknowledged that while estrogen may moderate emotional 
behaviour and testosterone moderate competitive behaviour as I have argued, it is 
possible that a third hormone or relative ratios of several hormones combined 
explain the documented effects. Not until longitudinal within-subject research has 
been conducted which assays a range of hormones including estrogen, progesterone, 
testosterone, FSH and LH, can the explanations outlined above be validated. 
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The future of HC’s 
 
Overall, the results contained within this thesis point to a number of potentially 
negative consequences associated with HC use. This finding has the potential to be 
of direct societal relevance, given that more than 100 million women worldwide use 
HC’s (Trussell, 2007). The findings contained within this thesis do not however 
speak towards the idea of whether or not a woman should or should not use HC. 
This decision is a complex choice that is likely to be best resolved at an individual 
level. However, I believe that adequate knowledge of the risks, whether they are 
physical or psychological, is essential to make an informed decision to use HC. Put 
simply, I acknowledge that HC’s are associated with a number of positive health 
benefits (e.g., Huber et al., 2008) and have facilitated a great deal of positive social 
change (e.g., Goldin & Katz, 2002); however, I would argue that the development 
of HC is far from complete. Subtle psychological changes have just recently been 
recognized as a common reason for discontinuing use of HC’s (Sanders et al., 
2001). Therefore, a major implication of this research is that it calls for additional 
large scale clinically controlled trials which investigate HC pill effects on female 
psychology.  
 
As researchers from a variety of disciplines begin to show increasingly convergent 
evidence for negative psychological consequences of HC use the pressure for 
pharmaceutical companies to direct funding towards testing these findings will 
increase. While companies may initially prove reluctant to test their drug for fear of 
negative findings, the widespread acknowledgement of psychological changes 
during HC use may one day motivate the development and testing of new HC 
combinations that limit the experience of these side effects. One example of 
innovation in this respect can be observed at Pantahrhei BV, a Dutch specialty 
pharmaceutical company, which recently condicted trials of a new HC that uses a 
third synthetic hormone (DHEA) to restore levels of androgens in the body in an 
effort to mitigate mood and sexuality changes among users (Zimmerman et al., in 
press). I suspect that the eventual acknowledgement of psychological effects of 
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HC’s by large scale pharmaceutical companies working to develop HC’s will 
generate a competitive market in this industry: who will be the first to develop and 
market a HC which retains contraceptive efficiency, maintains low levels of 
physical symptomology and reduces psychological disruption? Since HC’s are 
among the most prescribed drugs in the world, the development of such a HC is 




It may seem that, in many respects, this thesis generates more questions than it 
provides answers. Nevertheless, in light of the findings within this thesis we can 
conclude a number of things. A great deal of this thesis targeted the investigation of 
the hormonal influences of jealousy. While I am confident that cycle shifts in 
jealousy occur (Chapter Two; Chapter Three; Geary et al., 2001) and that HC use 
influences the expression of jealousy (Chapter Two; Chapter Four; Chapter Five) I 
was unable to specify how these shifts may be adaptive. It appears that such shifts 
are not guided by intrasexual competition (Chapter Six) or changes in self-
perceptions of attractiveness (Chapter Seven), though these variables proved 
interesting when considering HC effects. Given that estrogen peaks mid-cycle when 
fertile it is an obvious etiological candidate. I therefore argue that estrogen is likely 
to be the mechanism behind the observed patterns of jealousy but that cyclical shifts 
in jealousy are not adaptive. Jealousy may be a by-product of shifts in sexual desire 
but this remains to be tested in greater detail.  
 
Considering the strong evidence I have provided which shows that HC use 
influences intimate behaviour, there is a real and timely need for large scale and 
clinically controlled trials to address these consequences more broadly. This thesis 
prompts three immediate opportunities for investigation: (1) large scale controlled 
trials of HC’s influence on interpersonal behaviour; (2) studies of how different 
types of HC’s differentially influence interpersonal behaviours; and (3) studies of 
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how the congruency between current use and use at the initiation of a romantic 
relationship influences interpersonal behaviour. While HC’s may have triumphed 
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Introductie 
De hormonale anticonceptiepil (HA) is het meest onderzochte medicijn ter wereld. 
Als gevolg hiervan is er reeds een grote hoeveelheid literatuur ter beschikking over 
de werking van de HA. Tot op de dag van vandaag richtte het onderzoek zich echter 
voornamelijk op de lichamelijke risicofactoren verbonden met het gebruik van de 
HA of op de sociale invloed die de introductie van een betrouwbare en reguleerbare 
anticonceptie op de rol van vrouwen in de maatschappij heeft gehad. Het is 
uiteraard positief dat deze belangrijke en relevante onderwerpen veel aandacht 
hebben gekregen. Echter, is er nog relatief weinig bekend over de psychologische 
bijwerkingen van de HA. Dit proefschrift richtte zich op de effecten van HA op 
jaloezie en competitie met andere vrouwen. Dit onderwerp wordt in het proefschrift 
benaderd vanuit een evolutionair psychologisch (EP) perspectief met de nadruk op 
biologische invloeden. EP benadert menselijk gedrag vanuit een ‘adaptief’ 
perspectief. Volgens dit perspectief worden fysiologische systemen gevormd 
middels natuurlijke selectie. EP probeert te doorgronden hoe bepaalde 
eigenschappen een organisme kunnen helpen om te overleven en/of zich voort te 
planten. De EP benadering biedt relevante theoretische inzichten betreffende de 
gedragsveranderingen die men kan verwachten als gevolg van het gebruik van HA. 
Mijn initiële benadering voor het onderzoeken van de psychologische effecten van 
HA kwam voort uit literatuur die psychologische veranderingen beschreef in 
vrouwen tijdens de menstruatiecyclus. Vrouwen die geen gebruik maken van de HA 
vertonen duidelijke veranderingen in hun partnervoorkeuren en gedrag bij de 
overgang van de vruchtbare naar de niet-vruchtbare periode in hun cyclus. Deze 
psychologische veranderingen tijdens de vruchtbare periode worden gezien als 
evolutionair voordelig omdat ze ervoor zorgen dat vrouwen zich voortplanten met 
partners van hogere kwaliteit en op die manier betere genen doorgeven aan hun 
nakomelingen. Echter, de hormonen die fluctueren tijdens de vruchtbare periode, 
het vermoedelijke mechanisme achter de psychologische veranderingen, worden 
onderdrukt bij het gebruik van HA. Dat zou kunnen leiden tot minder adaptief 
gedrag bij HA gebruikers. Vanuit deze benadering beargumenteer ik in dit 
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proefschrift dat het gebruik van HA de voorkeuren en het gedrag van vrouwen 
verandert in vergelijking met vrouwen met een natuurlijke menstruatiecyclus. 
Tevens lever ik bewijs dat de verstoring van de natuurlijke vruchtbaarheidscyclus 
psychologische gevolgen kan hebben voor de dynamiek binnen intieme relaties. 
Samenvatting van de empirische resultaten 
Dit proefschrift is opgedeeld in twee delen, welke ik hieronder kort zal beschrijven. 
Deel 1: Hormonale effecten op jaloezie in vrouwen 
In Hoofdstukken 2 tot en met 5 werden de effecten van de HA op het de beleving 
van jaloezie in vrouwen onderzocht. Jaloezie kan voor vrouwen als evolutionair 
voordelig worden gezien, aangezien ze op deze manier kan voorkomen dat haar 
partner haar verlaat of in relaties met andere vrouwen investeert. Hoofdstuk Twee 
beschrijft de resultaten van een binnen proefpersonen experiment waarin 
zelfgeraporteerd jaloers gedrag van vrouwen werd vastgesteld tijdens de vruchtbare 
en niet-vruchtbare periode van de cyclus, alsmede wanneer zij HA gebruikten. De 
resultaten toonden aan dat de mate van jaloezie hoger was tijdens de vruchtbare 
periode dan in de niet-vruchtbare periode. Voor vrouwen met een partner was de 
mate van jaloezie wanneer zij HA gebruikten vergelijkbaar met de mate van 
jaloezie tijdens de vruchtbare periode. Dit suggereert dat het gebruik van de HA de 
beleving van jaloezie binnen een relatie verandert, in ieder geval voor vrouwen met 
een partner. Naar mijn weten is dit pas het derde gepubliceerde onderzoek waarin 
gebruik wordt gemaakt van een binnen proefpersonen design waarin vrouwen 
afwisselend wel of niet de pil slikten, en het eerste onderzoek dat specifiek jaloezie 
onderzocht. Ook methodologisch draagt het artikel bij aan het onderzoeksveld, door 
middel van het binnen proefpersonen benadering alsmede door het gebruik van 
transvaginale echografie, waarmee het een standaard zet voor toekomstig onderzoek 
naar HA en de menstruatie cyclus. 
In Hoofdstuk 3 werden de veranderingen in jaloezie gedurende de menstruatie 
cyclus onderzocht bij vrouwen uit Willemstad, Curaçao. Het overgrote deel van 
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onderzoek naar veranderingen in vrouwelijke voorkeuren en gedrag gedurende de 
cyclus betreft onderzoeken met westerse, blanke studenten; een tekortkoming die in 
het algemeen geldt voor psychologisch onderzoek. In tegenstelling tot Hoofdstuk 2, 
is in Hoofdstuk 3 gebruik gemaakt van een tussen proefpersonen experiment om de 
steekproef te kunnen vergroten. In overeenstemming met de resultaten van 
Hoofdstuk 2, toonden de resultaten aan dat vrouwen een significant hogere mate 
van jaloezie rapporteerden tijdens de vruchtbare periode, in vergelijking met de 
niet-vruchtbare periode van hun menstruatie cyclus. Deze resultaten bleven 
behouden wanneer er gecorrigeerd werd voor leeftijd, relatiestatus en tevredenheid 
met de relatie. De resultaten van dit onderzoek, in combinatie met de resultaten in 
Hoofdstuk 2, suggereren dat veranderingen in jaloezie gedurende de menstruatie 
cyclus robuust zijn, aangezien ze aangetoond worden in verschillende culturen en 
met behulp van verschillende onderzoeksmethoden. Wanneer men de resultaten van 
Hoofdstuk 2 en 3 samen neemt, is het interessant om op te merken dat, hoewel 
veranderingen in jaloezie gedurende de menstruatie cyclus vergelijkbaar waren in 
beide onderzoeken, de mate van jaloezie bij vrouwen uit Curaçao significant hoger 
was.  
Op basis van het effect van de pil in vrouwen met een partner dat gevonden werd in 
Hoofdstuk 2, ontwikkelde ik een vervolgonderzoek om vast te stellen of 
verschillende HA's jaloezie in dezelfde mate verhogen. De meest gebruikte vorm 
van HA, de gecombineerde orale anticonceptiepil, bestaat uit synthetische 
oestrogenen en progesteron. Er zijn echter verscheidene soorten HA pillen 
beschikbaar voor vrouwen, die verschillen in de concentratie oestrogenen en 
progesteron. Om te onderzoeken of deze anticonceptie pillen variëren in hun effect 
op jaloezie, maakte ik gebruik van een groot aantal vrouwen die verschillende 
vormen van de gecombineerde HA pil gebruikten. In Hoofdstuk 4 rapporteer ik de 
resultaten van dit onderzoek. Vrouwen die een pil gebruikten met een hogere dosis 
oestrogenen rapporteerden een hogere mate van jaloezie dan vrouwen die een pil 
gebruikten met een lagere dosis oestrogenen. Dit resultaat bleef gelijk wanneer er 
gecorrigeerd werd voor leeftijd, relatiestatus, en de hoogte van de dosis syntethische 
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progesteron. Dit is naar mijn weten het eerste onderzoek dat de effecten van de 
anticonceptie pil op het sociale gedrag van vrouwen in meer detail heeft onderzocht. 
De resultaten van dit onderzoek suggereren dat onderzoek waarin slechts een 
vergelijking wordt gemaakt tussen 'pil gebruiker' en 'geen pil gebruiker' een 
dergelijk complex effect van de pil te kort doet. Sinds de publicatie van het 
onderzoek uit Hoofdstuk 4 zijn de resultaten gerepliceerd door een Amerikaanse 
onderzoeksgroep met betrekking tot controlegedrag door een partner. Dit suggereert 
dat de resultaten redelijk robuust zijn.  
Hoofdstuk 5 beschrijft de resultaten van een onderzoek waarin gekeken werd of een 
geschiedenis van het gebruik van hormonale anticonceptie de huidige mate van 
jaloezie beïnvloedt. De resultaten toonden aan dat jaloezie binnen de relatie hoger is 
bij koppels waarbij het huidige hormonale contraceptie gebruik verschilt met het 
gebruik tijdens het begin van de relatie. Anders gezegd, koppels waarbij HA 
gebruik overeenkomt met het gebruik in het begin van de relatie rapporteerden een 
lagere mate van jaloezie. Dit suggereert dat voorkeuren die de overhand hebben aan 
het begin van de relatie veranderd zijn wanneer er begonnen of gestopt wordt met 
het gebruik van HA tijdens de relatie en dat deze wijziging in pilgebruik invloed 
heeft op de dynamiek binnen de relatie. Dat het gebruik van HA aan het begin van 
de relatie aspecten van tevredenheid met die relatie op een later tijdstip voorspelt, 
kan relevant zijn voor artsen die anticonceptiva voorschrijven alsmede voor 
degenen die advies geven over het gebruik van anticonceptie. 
Deel 2: Verklaringen voor veranderingen in jaloezie: De rol van aantrekkelijkheid 
en intraseksuele competitie 
In Hoofdstukken 6 en 7 heb ik geprobeerd het mechanisme achter de veranderingen 
in jaloezie gedurende de menstruatie cyclus en gedurende het gebruik van de 
anticonceptie pil te ontrafelen. Het is niet direct duidelijk waarom in de vruchtbare 
periode veranderingen in de mate van jaloezie evolutionair voordelig zouden zijn. 
Een mogelijkheid is dat een hogere mate van jaloezie tijdens de vruchtbare periode 
een uiting kan zijn van een hogere mate van intraseksuele competitie tijdens deze 
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periode. Een verhoogde mate van competitie tijdens de vruchtbare periode zou 
wellicht een vrouw kunnen helpen om gemakkelijker een partner van hoge kwaliteit 
te krijgen of te behouden dan anders mogelijk zou zijn. 
Ik onderzocht deze mogelijkheid in Hoofdstuk 6, door de mate van intraseksuele 
competitie te onderzoeken in een groep vrouwen die in eerste instantie de pil 
gebruikten maar vervolgens stopten met het gebruik. Het betrof opnieuw een binnen 
proefpersonen ontwerp. De proefpersonen rapporteerden de mate van intraseksuele 
competitie die zij ervoeren terwijl zij de pil gebruikten en gedurende een 
regelmatige menstruatie cyclus, zowel tijdens de vruchtbare en niet vruchtbare 
periode van deze cyclus. De resultaten toonden aan dat bij vrouwen met een partner, 
maar niet bij vrouwen zonder partner, de mate van intraseksuele competitie lager 
was wanneer zij de HA gebruikten dan tijdens een natuurlijke menstruatie cyclus. 
Zowel voor vrouwen zonder partner als voor vrouwen met een partner werden er 
geen veranderingen in intraseksuele competitie geobserveerd gedurende de 
verschillende periodes van de menstruatie cyclus. Dit lijkt het erop te wijzen dat de 
eerdergenoemde toename in jaloezie tijdens de vruchtbare periode niet verklaard 
kunnen worden door een toename van intraseksuele competitie. De bevinding dat 
intraseksuele competitie lager is in pilgebruikers (bij wie testosteron onderdrukt 
wordt) is echter in overeenstemming met het idee dat testosteron competitief gedrag 
beïnvloedt. Gezien de afwezigheid van wisselingen in intraseksuele competitie 
tijdens de menstruatie cyclus en het gegeven dat het gehalte van testosteron niet 
substantieel verandert tijdens de menstruatie cyclus, terwijl de niveaus van 
oestrogenen en progesteron juist wel fluctueren, kan testosteron mogelijkerwijs het 
lagere niveau van intraseksuele competitie bij pilgebruikers verklaren. 
In Hoodstuk 7 volgde ik een kleine groep vrouwen en hun mannelijke partner 
gedurende de menstruatie cyclus en gedurende het gebruik van de pil, vergelijkbaar 
met Hoofdstukken 2 en 6. Een reeks onderzoeken in verschillende psychologie-
laboratoria hebben aangetoond dat vrouwen als meer aantrekkelijk worden 
beoordeeld tijdens hun vruchtbare periode in vergelijking met de niet-vruchtbare 
periode. Mijn onderzoek liet zien dat mannen hun vrouwelijke partners als 
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significant aantrekkelijker beoordelen wanneer zij vruchtbaar is dan wanneer zij 
niet vruchtbaar is of HA gebruikt. Tevens vonden de mannen zichzelf significant 
aantrekkelijker wanneer de vrouwelijke partner een natuurlijke menstruatie cyclus 
had dan wanneer zij HA gebruikte. Ondanks deze patronen rapporteerden vrouwen 
zelf geen verschillen in de perceptie van hun eigen aantrekkelijkheid over de 
verschillende condities. Er lijken desalniettemin onbewuste veranderingen op te 
treden in de waarneming van mannen, die mogelijk bijdragen aan de veranderingen 
in de mate van jaloezie in vrouwen.  
Conclusie 
Het onderzoek beschreven in dit proefschrift wijst op niet eerder vastgestelde 
negatieve bijwerkingen van HA gebruik. Een groot gedeelte van dit onderzoek 
betrof de mechanismen verantwoordelijk voor veranderingen in jaloezie. Hoewel ik 
overtuigd ben van het bestaan cyclische veranderingen in jaloezie (Hoofdstuk Twee, 
Hoofdstuk Drie) en dat jaloezie beïnvloed wordt door HA gebruik, is het niet direct 
duidelijk wat de adaptieve functie van deze veranderingen in jaloezie zijn. Ze lijken 
niet voort te komen uit veranderingen in intraseksuele competitie (Hoofdstuk Zes) 
of veranderingen in percepties van eigen aantrekkelijkheid (Hoofdstuk Zeven), 
alhoewel deze variabelen wel interessant zijn in het licht van HA pil effecten. 
Aangezien het gehalte van oestrogeen piekt gedurende het midden van de cyclus en 
de hoogste mate van jaloezie ook in deze periode wordt gevonden, betoog ik dat 
oestrogeen waarschijnlijk het mechanisme is achter de geobserveerde patronen in 
jaloezie. Zowel het binnen proefpersonen design als de stringente criteria gebruikt 
om vruchtbaarheid te bepalen, zoals gebruikt in het onderzoek van dit proefschrift, 
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